www.onclive.com Open in urlscan Pro
52.206.141.94 Public Scan

Go To Rescan
Add Verdict Report

Submitted URL:
http://mailview.bulletinhealthcare.com/mailview.aspx?m=2019101801ashp&r=9372293-2288&l=00f-288&t=c
Effective URL:
https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Submission: On October 18 via api (October 18th 2019, 3:03:41 pm UTC) from US

Summary HTTP 121 Redirects Links 27 Behaviour Indicators

Summary

This website contacted 32 IPs in 6 countries across 28 domains to perform 121 HTTP transactions. The main IP is 52.206.141.94, located in Ashburn, United States and belongs to AMAZON-AES - Amazon.com, Inc., US. The main domain is www.onclive.com.
TLS certificate: Issued by Amazon on May 6th 2019. Valid for: a year.

This is the only time www.onclive.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

	IP Address	AS Autonomous System
1 1	69.174.55.131 69.174.55.131	3257 (GTT-BACKB...) (GTT-BACKBONE GTT)
6 18	52.206.141.94 52.206.141.94	14618 (AMAZON-AES) (AMAZON-AES - Amazon.com)
3	2a00:1450:400... 2a00:1450:4001:800::200a	15169 (GOOGLE) (GOOGLE - Google LLC)
3	23.111.9.35 23.111.9.35	33438 (HIGHWINDS2) (HIGHWINDS2 - Highwinds Network Group)
5	52.20.98.150 52.20.98.150	14618 (AMAZON-AES) (AMAZON-AES - Amazon.com)
43	52.216.184.59 52.216.184.59	16509 (AMAZON-02) (AMAZON-02 - Amazon.com)
1	2a04:4e42:1b:... 2a04:4e42:1b::621	54113 (FASTLY) (FASTLY - Fastly)
8	2600:9000:21f... 2600:9000:21f3:6200:3:c04e:c780:93a1	16509 (AMAZON-02) (AMAZON-02 - Amazon.com)
2	52.216.164.101 52.216.164.101	16509 (AMAZON-02) (AMAZON-02 - Amazon.com)
1	2a00:1450:400... 2a00:1450:4001:81a::2008	15169 (GOOGLE) (GOOGLE - Google LLC)
1 5	2a00:1450:400... 2a00:1450:4001:815::2002	15169 (GOOGLE) (GOOGLE - Google LLC)
1 3	2a00:1450:400... 2a00:1450:4001:815::200e	15169 (GOOGLE) (GOOGLE - Google LLC)
1	147.75.33.59 147.75.33.59	54825 (PACKET) (PACKET - Packet Host)
2	172.217.21.194 172.217.21.194	15169 (GOOGLE) (GOOGLE - Google LLC)
1	151.101.13.131 151.101.13.131	54113 (FASTLY) (FASTLY - Fastly)
3	172.217.23.98 172.217.23.98	15169 (GOOGLE) (GOOGLE - Google LLC)
1 1	2a00:1450:400... 2a00:1450:400c:c04::9a	15169 (GOOGLE) (GOOGLE - Google LLC)
2 3	2a00:1450:400... 2a00:1450:4001:81d::2004	15169 (GOOGLE) (GOOGLE - Google LLC)
3	2a00:1450:400... 2a00:1450:4001:819::2003	15169 (GOOGLE) (GOOGLE - Google LLC)
1	143.204.98.216 143.204.98.216	16509 (AMAZON-02) (AMAZON-02 - Amazon.com)
2	147.75.84.33 147.75.84.33	54825 (PACKET) (PACKET - Packet Host)
1	151.101.112.157 151.101.112.157	54113 (FASTLY) (FASTLY - Fastly)
6	151.101.12.175 151.101.12.175	54113 (FASTLY) (FASTLY - Fastly)
1	2600:9000:215... 2600:9000:2156:8600:c:a9b7:ddc0:93a1	16509 (AMAZON-02) (AMAZON-02 - Amazon.com)
1	2a00:1450:400... 2a00:1450:4001:809::200e	15169 (GOOGLE) (GOOGLE - Google LLC)
1 2	3.123.152.53 3.123.152.53	16509 (AMAZON-02) (AMAZON-02 - Amazon.com)
1	2a00:1450:400... 2a00:1450:4001:809::2001	15169 (GOOGLE) (GOOGLE - Google LLC)
1	54.230.95.226 54.230.95.226	16509 (AMAZON-02) (AMAZON-02 - Amazon.com)
3	54.171.133.34 54.171.133.34	16509 (AMAZON-02) (AMAZON-02 - Amazon.com)
1	104.244.42.5 104.244.42.5	13414 (TWITTER) (TWITTER - Twitter Inc.)
2	104.109.80.105 104.109.80.105	20940 (AKAMAI-ASN1) (AKAMAI-ASN1)
2	2a03:2880:f00... 2a03:2880:f007:8:face:b00c:0:1	32934 (FACEBOOK) (FACEBOOK - Facebook)
2	2a03:2880:f10... 2a03:2880:f107:83:face:b00c:0:25de	32934 (FACEBOOK) (FACEBOOK - Facebook)
1	104.244.42.67 104.244.42.67	13414 (TWITTER) (TWITTER - Twitter Inc.)
121	32

1 69.174.55.131 (United States) 1 redirects

ASN3257 (GTT-BACKBONE GTT, DE)
PTR: colo131b.bulletinintelligence.com

mailview.bulletinhealthcare.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

18 52.206.141.94 (Ashburn, United States) 6 redirects

ASN14618 (AMAZON-AES - Amazon.com, Inc., US)
PTR: ec2-52-206-141-94.compute-1.amazonaws.com

www.onclive.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 2a00:1450:4001:800::200a (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)

ajax.googleapis.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 23.111.9.35 (Phoenix, United States)

ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US)

use.fontawesome.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

5 52.20.98.150 (Ashburn, United States)

ASN14618 (AMAZON-AES - Amazon.com, Inc., US)
PTR: ec2-52-20-98-150.compute-1.amazonaws.com

lucid.mjhassoc.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

43 52.216.184.59 (Ashburn, United States)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
PTR: s3-1-w.amazonaws.com

onclive.s3.amazonaws.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a04:4e42:1b::621 (Ascension Island)

ASN54113 (FASTLY - Fastly, US)

cdn.jsdelivr.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

8 2600:9000:21f3:6200:3:c04e:c780:93a1 (United States)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)

ws.sharethis.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 52.216.164.101 (Ashburn, United States)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)

s3.amazonaws.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:81a::2008 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)

www.googletagmanager.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

5 2a00:1450:4001:815::2002 (Frankfurt am Main, Germany) 1 redirects

ASN15169 (GOOGLE - Google LLC, US)

www.googletagservices.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
adservice.google.de	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
adservice.google.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
googleads.g.doubleclick.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 2a00:1450:4001:815::200e (Frankfurt am Main, Germany) 1 redirects

ASN15169 (GOOGLE - Google LLC, US)

www.google-analytics.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
www.youtube.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 147.75.33.59 (Amsterdam, Netherlands)

ASN54825 (PACKET - Packet Host, Inc., US)
PTR: pkt-ams-k1-4

static.hotjar.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 172.217.21.194 (United States)

ASN15169 (GOOGLE - Google LLC, US)
PTR: fra16s12-in-f2.1e100.net

www.googleadservices.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 151.101.13.131 (Frankfurt am Main, Germany)

ASN54113 (FASTLY - Fastly, US)

2bc72976f5be45bfaa237bd9b8fd5ddb.js.ubembed.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 172.217.23.98 (United States)

ASN15169 (GOOGLE - Google LLC, US)
PTR: fra16s45-in-f2.1e100.net

securepubads.g.doubleclick.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:400c:c04::9a (Brussels, Belgium) 1 redirects

ASN15169 (GOOGLE - Google LLC, US)

stats.g.doubleclick.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 2a00:1450:4001:81d::2004 (Frankfurt am Main, Germany) 2 redirects

ASN15169 (GOOGLE - Google LLC, US)

www.google.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 2a00:1450:4001:819::2003 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)

www.google.de	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 143.204.98.216 (Seattle, United States)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
PTR: server-143-204-98-216.fra50.r.cloudfront.net

d14575uifa02kd.cloudfront.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 147.75.84.33 (Parsippany, United States)

ASN54825 (PACKET - Packet Host, Inc., US)

script.hotjar.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
vars.hotjar.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 151.101.112.157 (Frankfurt am Main, Germany)

ASN54113 (FASTLY - Fastly, US)

static.ads-twitter.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

6 151.101.12.175 (Frankfurt am Main, Germany)

ASN54113 (FASTLY - Fastly, US)

cdn.krxd.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
consumer.krxd.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2600:9000:2156:8600:c:a9b7:ddc0:93a1 (United States)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)

c.sharethis.mgr.consensu.org	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:809::200e (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)

s.ytimg.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 3.123.152.53 (Frankfurt am Main, Germany) 1 redirects

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
PTR: ec2-3-123-152-53.eu-central-1.compute.amazonaws.com

l.sharethis.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:809::2001 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)

tpc.googlesyndication.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 54.230.95.226 (Seattle, United States)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
PTR: server-54-230-95-226.fra2.r.cloudfront.net

assets.ubembed.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 54.171.133.34 (Dublin, Ireland)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
PTR: ec2-54-171-133-34.eu-west-1.compute.amazonaws.com

beacon.krxd.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 104.244.42.5 (United States)

ASN13414 (TWITTER - Twitter Inc., US)

t.co	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 104.109.80.105 (Netherlands)

ASN20940 (AKAMAI-ASN1, US)
PTR: a104-109-80-105.deploy.static.akamaitechnologies.com

t.sharethis.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2a03:2880:f007:8:face:b00c:0:1 (Ireland)

ASN32934 (FACEBOOK - Facebook, Inc., US)

connect.facebook.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2a03:2880:f107:83:face:b00c:0:25de (Ireland)

ASN32934 (FACEBOOK - Facebook, Inc., US)

www.facebook.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 104.244.42.67 (United States)

ASN13414 (TWITTER - Twitter Inc., US)

analytics.twitter.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

	Apex Domain Subdomains	Transfer
45	amazonaws.com onclive.s3.amazonaws.com s3.amazonaws.com	9 MB
18	onclive.com 6 redirects www.onclive.com	51 KB
12	sharethis.com 1 redirects ws.sharethis.com l.sharethis.com t.sharethis.com	48 KB
9	krxd.net cdn.krxd.net consumer.krxd.net beacon.krxd.net	87 KB
6	doubleclick.net 2 redirects securepubads.g.doubleclick.net stats.g.doubleclick.net googleads.g.doubleclick.net	85 KB
5	mjhassoc.com lucid.mjhassoc.com	7 KB
4	google.com 2 redirects adservice.google.com www.google.com	2 KB
4	google.de adservice.google.de www.google.de	985 B
3	hotjar.com static.hotjar.com script.hotjar.com vars.hotjar.com	76 KB
3	fontawesome.com use.fontawesome.com	40 KB
3	googleapis.com ajax.googleapis.com	99 KB
2	facebook.com www.facebook.com	495 B
2	facebook.net connect.facebook.net	88 KB
2	ubembed.com 2bc72976f5be45bfaa237bd9b8fd5ddb.js.ubembed.com assets.ubembed.com	46 KB
2	googleadservices.com www.googleadservices.com	10 KB
2	google-analytics.com 1 redirects www.google-analytics.com	18 KB
1	twitter.com analytics.twitter.com	634 B
1	t.co t.co	449 B
1	googlesyndication.com tpc.googlesyndication.com
1	ytimg.com s.ytimg.com	9 KB
1	consensu.org c.sharethis.mgr.consensu.org
1	ads-twitter.com static.ads-twitter.com	2 KB
1	youtube.com www.youtube.com	923 B
1	cloudfront.net d14575uifa02kd.cloudfront.net	4 KB
1	googletagservices.com www.googletagservices.com	15 KB
1	googletagmanager.com www.googletagmanager.com	33 KB
1	jsdelivr.net cdn.jsdelivr.net	2 KB
1	bulletinhealthcare.com 1 redirects mailview.bulletinhealthcare.com	420 B
121	28

	Domain	Requested by
43	onclive.s3.amazonaws.com	www.onclive.com ajax.googleapis.com
18	www.onclive.com	6 redirects www.onclive.com ajax.googleapis.com
8	ws.sharethis.com	www.onclive.com ws.sharethis.com
5	lucid.mjhassoc.com	www.onclive.com ajax.googleapis.com
3	beacon.krxd.net	cdn.krxd.net www.onclive.com
3	consumer.krxd.net	cdn.krxd.net
3	cdn.krxd.net	www.onclive.com cdn.krxd.net
3	www.google.de	www.onclive.com
3	www.google.com	2 redirects www.onclive.com
3	securepubads.g.doubleclick.net	www.googletagservices.com securepubads.g.doubleclick.net
3	use.fontawesome.com	www.onclive.com ajax.googleapis.com
3	ajax.googleapis.com	www.onclive.com
2	www.facebook.com	www.onclive.com
2	connect.facebook.net	www.onclive.com connect.facebook.net
2	t.sharethis.com	ws.sharethis.com t.sharethis.com
2	l.sharethis.com	1 redirects www.onclive.com
2	googleads.g.doubleclick.net	1 redirects www.googleadservices.com
2	www.googleadservices.com	www.googletagmanager.com www.googleadservices.com
2	www.google-analytics.com	1 redirects www.onclive.com
2	s3.amazonaws.com	www.onclive.com
1	analytics.twitter.com	static.ads-twitter.com
1	t.co	www.onclive.com
1	assets.ubembed.com	2bc72976f5be45bfaa237bd9b8fd5ddb.js.ubembed.com
1	tpc.googlesyndication.com	securepubads.g.doubleclick.net
1	vars.hotjar.com	static.hotjar.com
1	s.ytimg.com	www.youtube.com
1	c.sharethis.mgr.consensu.org	ws.sharethis.com
1	static.ads-twitter.com	www.onclive.com
1	script.hotjar.com	static.hotjar.com
1	www.youtube.com	lucid.mjhassoc.com
1	d14575uifa02kd.cloudfront.net	lucid.mjhassoc.com
1	stats.g.doubleclick.net	1 redirects
1	adservice.google.com	www.googletagservices.com
1	adservice.google.de	www.googletagservices.com
1	2bc72976f5be45bfaa237bd9b8fd5ddb.js.ubembed.com	www.googletagmanager.com
1	static.hotjar.com	www.googletagmanager.com
1	www.googletagservices.com	www.onclive.com
1	www.googletagmanager.com	www.onclive.com
1	cdn.jsdelivr.net	www.onclive.com
1	mailview.bulletinhealthcare.com	1 redirects
121	40

This site contains links to these domains. Also see Links.

Domain
www.gotoper.com
www.giantsofcancercare.com
www.isgio.org
community.onclive.com
www.webcasteventregistration.com
twitter.com
www.curetoday.com
www.mjhassoc.com
www.ajmc.com
www.hcplive.com
www.oncnursingnews.com
www.pharmacytimes.com
www.physiciansmoneydigest.com
www.specialtypharmacytimes.com
www.targetedonc.com
www.facebook.com
itunes.apple.com
www.youtube.com
www.linkedin.com

Subject Issuer	Validity	Valid
www.onclive.com Amazon	`2019-05-06` - `2020-06-06`	a year	crt.sh
*.googleapis.com GTS CA 1O1	`2019-10-03` - `2019-12-26`	3 months	crt.sh
*.fontawesome.com DigiCert SHA2 Secure Server CA	`2018-09-17` - `2019-11-21`	a year	crt.sh
lucid.mjhassoc.com Amazon	`2019-03-27` - `2020-04-27`	a year	crt.sh
*.s3.amazonaws.com DigiCert Baltimore CA-2 G2	`2018-11-07` - `2020-02-07`	a year	crt.sh
f3.shared.global.fastly.net GlobalSign CloudSSL CA - SHA256 - G3	`2019-05-29` - `2020-04-23`	a year	crt.sh
*.sharethis.com Go Daddy Secure Certificate Authority - G2	`2017-09-26` - `2020-09-29`	3 years	crt.sh
s3.amazonaws.com DigiCert Baltimore CA-2 G2	`2019-09-06` - `2020-12-02`	a year	crt.sh
*.google-analytics.com GTS CA 1O1	`2019-10-03` - `2019-12-26`	3 months	crt.sh
*.g.doubleclick.net GTS CA 1O1	`2019-10-03` - `2019-12-26`	3 months	crt.sh
*.google.com GTS CA 1O1	`2019-10-03` - `2019-12-26`	3 months	crt.sh
static.hotjar.com Let's Encrypt Authority X3	`2019-10-06` - `2020-01-04`	3 months	crt.sh
www.googleadservices.com GTS CA 1O1	`2019-10-03` - `2019-12-26`	3 months	crt.sh
z.ssl.fastly.net GlobalSign CloudSSL CA - SHA256 - G3	`2019-09-11` - `2020-08-07`	a year	crt.sh
www.google.de GTS CA 1O1	`2019-10-03` - `2019-12-26`	3 months	crt.sh
*.cloudfront.net DigiCert Global CA G2	`2019-07-17` - `2020-07-05`	a year	crt.sh
script.hotjar.com Let's Encrypt Authority X3	`2019-10-06` - `2020-01-04`	3 months	crt.sh
ads-twitter.com DigiCert SHA2 High Assurance Server CA	`2019-08-14` - `2020-08-18`	a year	crt.sh
*.c.ssl.fastly.net GlobalSign CloudSSL CA - SHA256 - G3	`2019-08-23` - `2020-08-23`	a year	crt.sh
*.sharethis.mgr.consensu.org Go Daddy Secure Certificate Authority - G2	`2018-05-21` - `2020-05-21`	2 years	crt.sh
vars.hotjar.com Let's Encrypt Authority X3	`2019-10-06` - `2020-01-04`	3 months	crt.sh
tpc.googlesyndication.com GTS CA 1O1	`2019-10-03` - `2019-12-26`	3 months	crt.sh
www.google.com GTS CA 1O1	`2019-10-03` - `2019-12-26`	3 months	crt.sh
assets.ubembed.com Amazon	`2019-05-02` - `2020-06-02`	a year	crt.sh
*.krxd.net DigiCert SHA2 Secure Server CA	`2019-04-11` - `2020-04-11`	a year	crt.sh
t.co DigiCert SHA2 High Assurance Server CA	`2019-04-09` - `2020-04-01`	a year	crt.sh
cert1.a1.atm.aqfer.net Let's Encrypt Authority X3	`2019-10-17` - `2020-01-15`	3 months	crt.sh
*.facebook.com DigiCert SHA2 High Assurance Server CA	`2019-09-22` - `2019-12-20`	3 months	crt.sh
*.twitter.com DigiCert SHA2 High Assurance Server CA	`2019-04-09` - `2020-04-01`	a year	crt.sh

This page contains 5 frames:

Primary Page: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Frame ID: 6A2D2B49E28F8AB82086A91FD1D3DEFF
Requests: 117 HTTP requests in this frame

Frame: https://c.sharethis.mgr.consensu.org/portal.html
Frame ID: 810390A14F9E6305547AA4E2D007F9A9
Requests: 1 HTTP requests in this frame

Frame: https://vars.hotjar.com/box-74dcf4e32eff343c96838bf3a780ac1d.html
Frame ID: D38591F65454DB3C5D179D1FD85C4FE9
Requests: 1 HTTP requests in this frame

Frame: https://t.sharethis.com/a/t_.htm?ver=0.312.14687&cid=c010
Frame ID: F511C3B4E7BEDCDF51E1D6487FC3994B
Requests: 1 HTTP requests in this frame

Frame: https://ws.sharethis.com/secure/index.html
Frame ID: C778D1D188B90DF9E7C3A6862F00CBEC
Requests: 1 HTTP requests in this frame

Screenshot
Live screenshot

Full Image

Page URL History Show full URLs

http://mailview.bulletinhealthcare.com/mailview.aspx?m=2019101801ashp&r=9372293-2288&l=00f-288&t=c HTTP 302
https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-br... Page URL

Detected technologies

Ubuntu (Operating Systems) Expand

Overall confidence: 100%
Detected patterns

headers server /Ubuntu/i

Windows Server (Operating Systems) Expand

Overall confidence: 50%
Detected patterns

url /\.aspx?(?:$|\?)/i

Microsoft ASP.NET (Web Frameworks) Expand

Overall confidence: 100%
Detected patterns

url /\.aspx?(?:$|\?)/i

Apache (Web Servers) Expand

Overall confidence: 100%
Detected patterns

headers server /(?:Apache(?:$|\/([\d.]+)|[^\/-])|(?:^|\b)HTTPD)/i

IIS (Web Servers) Expand

Overall confidence: 50%
Detected patterns

url /\.aspx?(?:$|\?)/i

DoubleClick for Publishers (DFP) (Advertising Networks) Expand

Overall confidence: 100%
Detected patterns

script /googletagservices\.com\/tag\/js\/gpt(?:_mobile)?\.js/i

Facebook (Widgets) Expand

Overall confidence: 100%
Detected patterns

script /\/\/connect\.facebook\.net\/[^\/]*\/[a-z]*\.js/i

Font Awesome (Font Scripts) Expand

Overall confidence: 100%
Detected patterns

html /<link[^>]* href="https:\/\/use\.fontawesome\.com\/releases\/v([^>]+)\/css\//i

Google Analytics (Analytics) Expand

Overall confidence: 100%
Detected patterns

script /google-analytics\.com\/(?:ga|urchin|analytics)\.js/i

Google Tag Manager (Tag Managers) Expand

Overall confidence: 100%
Detected patterns

html //i

Hotjar (Analytics) Expand

Overall confidence: 100%
Detected patterns

script /^\/\/static\.hotjar\.com\/c\/hotjar-/i

jQuery (JavaScript Libraries) Expand

Overall confidence: 100%
Detected patterns

script /\/([\d.]+)\/jquery(?:\.min)?\.js/i
script /jquery.*\.js(?:\?ver(?:sion)?=([\d.]+))?/i
script /([\d.]+)\/jquery-ui(?:\.min)?\.js/i
script /jquery-ui.*\.js/i

jQuery UI (JavaScript Libraries) Expand

Overall confidence: 100%
Detected patterns

script /([\d.]+)\/jquery-ui(?:\.min)?\.js/i
script /jquery-ui.*\.js/i

Page Statistics

121
Requests

100 %
HTTPS

41 %
IPv6

28
Domains

40
Subdomains

32
IPs

6
Countries

9763 kB
Transfer

11562 kB
Size

0
Cookies

27 Outgoing links

These are links going to different origins than the main page.

URL: https://www.gotoper.com/conferences
Title: PER Conferences

Search URL Search Domain Scan URL

URL: https://www.giantsofcancercare.com/rsvp
Title: Giants of Cancer Care

Search URL Search Domain Scan URL

URL: https://www.isgio.org/
Title: ISGIO

Search URL Search Domain Scan URL

URL: https://community.onclive.com/pages/home
Title: OncLive Community

Search URL Search Domain Scan URL

URL: http://www.webcasteventregistration.com/TGCTtreatment
Title: Tune in to our upcoming broadcast to learn more about advances in the treatment of tenosynovial giant cell tumor. Register today!

Search URL Search Domain Scan URL

URL: https://twitter.com/jasoncology
Title: @jasoncology

Search URL Search Domain Scan URL

URL: http://www.gotoper.com/online-cme-activities/medical-crossfire/mxf-headio18
Title: Medical Crossfire®: How Can We Optimize Outcomes in Head and Neck Cancers with Immunotherapeutic Strategies?

Search URL Search Domain Scan URL

URL: http://www.gotoper.com/online-cme-activities/pcc/ppc-ibs18
Title: The Patient and Provider Connection™: Effective Communication to Optimize the Diagnosis and Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation

Search URL Search Domain Scan URL

URL: http://www.curetoday.com/publications/cure/2017/rare-cancer-summer-2017
Title:

Search URL Search Domain Scan URL

URL: http://www.curetoday.com/publications/heal/2017/summer-2017
Title:

Search URL Search Domain Scan URL

URL: http://www.curetoday.com/publications/extraordinary-healer/2017/extraordinary-healer-vol-11
Title:

Search URL Search Domain Scan URL

URL: http://www.mjhassoc.com/
Title: MJH Associates

Search URL Search Domain Scan URL

URL: http://www.ajmc.com/
Title: American Journal of Managed Care

Search URL Search Domain Scan URL

URL: http://www.curetoday.com/
Title: Cure

Search URL Search Domain Scan URL

URL: http://www.hcplive.com/
Title: MD Magazine

Search URL Search Domain Scan URL

URL: https://www.oncnursingnews.com/
Title: Oncology Nursing News

Search URL Search Domain Scan URL

URL: http://www.pharmacytimes.com/
Title: Pharmacy Times

Search URL Search Domain Scan URL

URL: http://www.gotoper.com/
Title: Physicians' Education Resource

Search URL Search Domain Scan URL

URL: http://www.physiciansmoneydigest.com/
Title: Physician's Money Digest

Search URL Search Domain Scan URL

URL: http://www.specialtypharmacytimes.com/
Title: Specialty Pharmacy Times

Search URL Search Domain Scan URL

URL: http://www.targetedonc.com/
Title: TargetedOnc

Search URL Search Domain Scan URL

URL: http://www.mjhassoc.com/careers
Title: Careers

Search URL Search Domain Scan URL

URL: http://www.facebook.com/OncLive
Title:

Search URL Search Domain Scan URL

URL: http://twitter.com/onclive
Title:

Search URL Search Domain Scan URL

URL: http://itunes.apple.com/app/onclive/id348226937
Title:

Search URL Search Domain Scan URL

URL: http://www.youtube.com/user/OncLiveTV
Title:

Search URL Search Domain Scan URL

URL: https://www.linkedin.com/groups/OncLive-4266350
Title:

Search URL Search Domain Scan URL

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

http://mailview.bulletinhealthcare.com/mailview.aspx?m=2019101801ashp&r=9372293-2288&l=00f-288&t=c HTTP 302
https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 20

https://www.onclive.com/_media/_upload_image/Michael_Untch_thumb_new.jpg HTTP 301
https://onclive.s3.amazonaws.com/_media/_upload_image/Michael_Untch_thumb_new.jpg

Request Chain 21

https://www.onclive.com/_media/_upload_image/Remens_thumb_small_new.jpg HTTP 301
https://onclive.s3.amazonaws.com/_media/_upload_image/Remens_thumb_small_new.jpg

Request Chain 22

https://www.onclive.com/_media/_upload_image/C-Kent-Osborne-new-small-thumb.jpg HTTP 301
https://onclive.s3.amazonaws.com/_media/_upload_image/C-Kent-Osborne-new-small-thumb.jpg

Request Chain 23

https://www.onclive.com/_media/_upload_image/Anders_website_128.jpg HTTP 301
https://onclive.s3.amazonaws.com/_media/_upload_image/Anders_website_128.jpg

Request Chain 24

https://www.onclive.com/_media/_upload_image/Bhave_website_136.jpg HTTP 301
https://onclive.s3.amazonaws.com/_media/_upload_image/Bhave_website_136.jpg

Request Chain 25

https://www.onclive.com/_media/_upload_image/Kelly_Westbrook_10.9.19-video-thumb.jpg HTTP 301
https://onclive.s3.amazonaws.com/_media/_upload_image/Kelly_Westbrook_10.9.19-video-thumb.jpg

Request Chain 68

https://www.google-analytics.com/r/collect?v=1&_v=j79&a=1327822741&t=pageview&_s=1&dl=https%3A%2F%2Fwww.onclive.com%2Fweb-exclusives%2Ffda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer&ul=en-us&de=UTF-8&dt=FDA%20Grants%20Trastuzumab%20Deruxtecan%20Priority%20Review%20for%20HER2%2B%20Breast%20Cancer&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&_u=IEBAAEAB~&jid=125417665&gjid=275879088&cid=588703558.1571410995&tid=UA-11140057-22&_gid=646766858.1571410995&_r=1&z=825255005 HTTP 302
https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-11140057-22&cid=588703558.1571410995&jid=125417665&_gid=646766858.1571410995&gjid=275879088&_v=j79&z=825255005 HTTP 302
https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-11140057-22&cid=588703558.1571410995&jid=125417665&_v=j79&z=825255005 HTTP 302
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-11140057-22&cid=588703558.1571410995&jid=125417665&_v=j79&z=825255005&slf_rd=1&random=1898419658

Request Chain 94

https://l.sharethis.com/pview?event=pview&version=buttons.js&lang=en&fpc=3c9de77-16ddf64e858-7327ece0-1&sessionID=1571410995288.70122&hostname=www.onclive.com&location=%2Fweb-exclusives%2Ffda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer&product=widget&stid=&fcmp=false&publisher=cf568e38-4bc7-433c-9762-707b9eee5576&refDomain=&refQuery=&consentDomain=.consensu.org&url=https%3A%2F%2Fwww.onclive.com%2Fweb-exclusives%2Ffda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer&sharURL=&buttonType=ERROR&destination=ERROR&source=ERROR&title=FDA%20Grants%20Trastuzumab%20Deruxtecan%20Priority%20Review%20for%20HER2%2B%20Breast%20Cancer&ts1571410995288.0=&sop=false HTTP 301
https://l.sharethis.com/sc?cm=ZGYABF2p1DYAAAAULhlPAw%3D%3D&uid=true&url=https%3A%2F%2Fwww.onclive.com%2Fweb-exclusives%2Ffda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer&sop=false

Request Chain 101

https://googleads.g.doubleclick.net/pagead/viewthroughconversion/842772104/?random=436361640&cv=9&fst=*&num=1&value=0&label=FIJpCP6O4XkQiN3ukQM&guid=ON&resp=GooglemKTybQhCsO&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=120&u_java=false&u_nplug=0&u_nmime=0&gtm=2wgaa0&sendb=1&ig=1&frm=0&url=https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer&tiba=FDA%20Grants%20Trastuzumab%20Deruxtecan%20Priority%20Review%20for%20HER2%2B%20Breast%20Cancer&async=1&fmt=3&ctc_id=CAIVAgAAAB0CAAAA&ct_cookie_present=false&ocp_id=M9SpXaa0Govt3wPd2bDACg&sscte=1&crd=&gtd=&eitems=ChAI8MWl7QUQuZXrzsqV56I0Eh0Anuk_jp9Pkmx55ZSPXE7Hgzdp1iUrFGn-wcpv_g HTTP 302
https://www.google.com/pagead/1p-conversion/842772104/?random=436361640&cv=9&fst=*&num=1&value=0&label=FIJpCP6O4XkQiN3ukQM&guid=ON&resp=GooglemKTybQhCsO&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=120&u_java=false&u_nplug=0&u_nmime=0&gtm=2wgaa0&sendb=1&ig=1&frm=0&url=https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer&tiba=FDA%20Grants%20Trastuzumab%20Deruxtecan%20Priority%20Review%20for%20HER2%2B%20Breast%20Cancer&async=1&fmt=3&ctc_id=CAIVAgAAAB0CAAAA&ct_cookie_present=false&sscte=1&crd=&gtd=&is_vtc=1&ocp_id=M9SpXaa0Govt3wPd2bDACg&eitems=ChAI8MWl7QUQuZXrzsqV56I0Eh0Anuk_jsaNbsrqbbL6hhsOd9FN0rXBHHkUX2z65g&random=3291780953&resp=GooglemKTybQhCsO HTTP 302
https://www.google.de/pagead/1p-conversion/842772104/?random=436361640&cv=9&fst=*&num=1&value=0&label=FIJpCP6O4XkQiN3ukQM&guid=ON&resp=GooglemKTybQhCsO&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=120&u_java=false&u_nplug=0&u_nmime=0&gtm=2wgaa0&sendb=1&ig=1&frm=0&url=https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer&tiba=FDA%20Grants%20Trastuzumab%20Deruxtecan%20Priority%20Review%20for%20HER2%2B%20Breast%20Cancer&async=1&fmt=3&ctc_id=CAIVAgAAAB0CAAAA&ct_cookie_present=false&sscte=1&crd=&gtd=&is_vtc=1&ocp_id=M9SpXaa0Govt3wPd2bDACg&eitems=ChAI8MWl7QUQuZXrzsqV56I0Eh0Anuk_jsaNbsrqbbL6hhsOd9FN0rXBHHkUX2z65g&random=3291780953&resp=GooglemKTybQhCsO&ipr=y

121 HTTP transactions
0 data transactions

Method
Protocol Status Resource
Path Size
x-fer Time
Latency Type
MIME-Type IP
Location

GET
H2

200

Primary Request fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer Show response
www.onclive.com/web-exclusives/
Redirect Chain

http://mailview.bulletinhealthcare.com/mailview.aspx?m=2019101801ashp&r=9372293-2288&l=00f-288&t=c
https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

63 KB
13 KB

3767ms
537ms

Document
text/html

52.206.141.94
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL

https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

52.206.141.94 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),

Reverse DNS

ec2-52-206-141-94.compute-1.amazonaws.com

Software

Apache/2.4.7 (Ubuntu) / PHP/5.5.9-1ubuntu4.22

Resource Hash

6f2a972409ccf032752fdfd99b8f7a980691e99d2e84edcf813a9964501d4622

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

:method: GET
:authority: www.onclive.com
:scheme: https
:path: /web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
pragma: no-cache
cache-control: no-cache
upgrade-insecure-requests: 1
user-agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
accept: text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site: none
accept-encoding: gzip, deflate, br
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status: 200
date: Fri, 18 Oct 2019 15:03:14 GMT
content-type: text/html
content-length: 12546
server: Apache/2.4.7 (Ubuntu)
x-powered-by: PHP/5.5.9-1ubuntu4.22
set-cookie: LUCIDSESSID=2c6687150b2f6d80604bcdefc2cdb611; expires=Sat, 17-Oct-2020 15:03:14 GMT; Max-Age=31536000; path=/ PHPSESSID=voma367jhqsndpqclufbrrl992; path=/ LUCIDSESSID=2c6687150b2f6d80604bcdefc2cdb611; expires=Sat, 17-Oct-2020 15:03:14 GMT; Max-Age=31536000; path=/ LUCIDSESSID=2c6687150b2f6d80604bcdefc2cdb611; expires=Sat, 17-Oct-2020 15:03:14 GMT; Max-Age=31536000; path=/ LUCIDSESSID=2c6687150b2f6d80604bcdefc2cdb611; expires=Sat, 17-Oct-2020 15:03:14 GMT; Max-Age=31536000; path=/ LUCIDSESSID=2c6687150b2f6d80604bcdefc2cdb611; expires=Sat, 17-Oct-2020 15:03:14 GMT; Max-Age=31536000; path=/ LUCIDSESSID=2c6687150b2f6d80604bcdefc2cdb611; expires=Sat, 17-Oct-2020 15:03:14 GMT; Max-Age=31536000; path=/ LUCIDSESSID=2c6687150b2f6d80604bcdefc2cdb611; expires=Sat, 17-Oct-2020 15:03:14 GMT; Max-Age=31536000; path=/ AT2=5049b441f2a5178374812ddbbc41c8fc; expires=Sat, 17-Oct-2020 15:03:14 GMT; Max-Age=31536000; path=/
expires: Thu, 19 Nov 1981 08:52:00 GMT
cache-control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
pragma: no-cache
vary: Accept-Encoding
content-encoding: gzip
content-security-policy: upgrade-insecure-requests

Redirect headers

Cache-Control: private
Content-Type: text/html; charset=utf-8
Location: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Server: Microsoft-IIS/10.0
Set-Cookie: ASP.NET_SessionId=l0wrm03olazc1kq42difrdbm; path=/; HttpOnly
X-AspNet-Version: 4.0.30319
X-BNN-Server: biapp1
Date: Fri, 18 Oct 2019 15:03:10 GMT
Content-Length: 228

GET
H2 200 jquery.min.js Show response
ajax.googleapis.com/ajax/libs/jquery/2.1.4/ 82 KB
29 KB 7ms
5ms Script
text/javascript 2a00:1450:4001:800::200a
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://ajax.googleapis.com/ajax/libs/jquery/2.1.4/jquery.min.js

Requested by

Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:800::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

sffe /

Resource Hash

22642f202577f0ba2f22cbe56b6cf291a09374487567cd3563e0d2a29f75c0c5

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Thu, 17 Oct 2019 11:35:23 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 98871
status: 200
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 29725
x-xss-protection: 0
last-modified: Tue, 20 Dec 2016 18:17:03 GMT
server: sffe
vary: Accept-Encoding
content-type: text/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: public, max-age=31536000, stale-while-revalidate=2592000
accept-ranges: bytes
timing-allow-origin: *
expires: Fri, 16 Oct 2020 11:35:23 GMT

GET
H2 200 all.css
use.fontawesome.com/releases/v5.8.1/css/ 54 KB
14 KB 57ms
19ms Stylesheet
text/css 23.111.9.35
Highwinds Network...

General

Check archive.org

Show headers Download Go to

Full URL: https://use.fontawesome.com/releases/v5.8.1/css/all.css
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 23.111.9.35 Phoenix, United States, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
Software: NetDNA-cache/2.2 /
Resource Hash: eeb17a45a48aca1d7adbcf04de155dcd0b47cb36ad036310446bb471fea9aaa3

Request headers

Sec-Fetch-Mode: cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Origin: https://www.onclive.com
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:14 GMT
content-encoding: gzip
last-modified: Thu, 21 Mar 2019 21:31:35 GMT
server: NetDNA-cache/2.2
status: 200
etag: W/"e4c542a7f6bf6f74fdd8cdf6e8096396"
vary: Origin, Access-Control-Request-Headers, Access-Control-Request-Method, Accept-Encoding
access-control-allow-methods: GET
content-type: text/css
access-control-allow-origin: *
access-control-max-age: 3000
cache-control: max-age=31556926
x-cache: HIT

GET
H2 200 jquery-ui.min.css
ajax.googleapis.com/ajax/libs/jqueryui/1.11.4/themes/smoothness/ 29 KB
7 KB 14ms
12ms Stylesheet
text/css 2a00:1450:4001:800::200a
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://ajax.googleapis.com/ajax/libs/jqueryui/1.11.4/themes/smoothness/jquery-ui.min.css

Requested by

Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:800::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

sffe /

Resource Hash

8964f1fe20bd22829aa12283e7e59515e7fc658348810e00c55a4c6c1c368628

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 11 Oct 2019 17:33:19 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 595795
status: 200
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 7320
x-xss-protection: 0
last-modified: Tue, 20 Dec 2016 18:17:03 GMT
server: sffe
vary: Accept-Encoding
content-type: text/css; charset=UTF-8
access-control-allow-origin: *
cache-control: public, max-age=31536000, stale-while-revalidate=2592000
accept-ranges: bytes
timing-allow-origin: *
expires: Sat, 10 Oct 2020 17:33:19 GMT

GET
H2 200 jquery-ui.min.js Show response
ajax.googleapis.com/ajax/libs/jqueryui/1.11.4/ 235 KB
63 KB 9ms
7ms Script
text/javascript 2a00:1450:4001:800::200a
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://ajax.googleapis.com/ajax/libs/jqueryui/1.11.4/jquery-ui.min.js

Requested by

Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:800::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

sffe /

Resource Hash

c4d8dbe77feb63e5a61bee0bead4e5f66e8fa6a927599bd1b74aced52467273c

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Thu, 10 Oct 2019 11:50:41 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 702753
status: 200
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 64481
x-xss-protection: 0
last-modified: Tue, 20 Dec 2016 18:17:03 GMT
server: sffe
vary: Accept-Encoding
content-type: text/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: public, max-age=31536000, stale-while-revalidate=2592000
accept-ranges: bytes
timing-allow-origin: *
expires: Fri, 09 Oct 2020 11:50:41 GMT

GET
H2 200 frame.js Show response
www.onclive.com/ 5 KB
2 KB 198ms
197ms Script
application/javascript 52.206.141.94
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL

https://www.onclive.com/frame.js?v=2.1

Requested by

Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

52.206.141.94 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),

Reverse DNS

ec2-52-206-141-94.compute-1.amazonaws.com

Software

Apache/2.4.7 (Ubuntu) /

Resource Hash

bae0f298d7aa902d6cfdfdd201399d6de6341cab7434c6d2fd067a9608f845b2

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:15 GMT
content-encoding: gzip
last-modified: Tue, 15 Oct 2019 20:56:04 GMT
server: Apache/2.4.7 (Ubuntu)
etag: "13b7-594f9366c3fc4-gzip"
vary: Accept-Encoding
content-type: application/javascript
status: 200
content-security-policy: upgrade-insecure-requests
accept-ranges: bytes
content-length: 1516

GET
H2 200 common.js Show response
www.onclive.com/ 5 KB
1 KB 127ms
127ms Script
application/javascript 52.206.141.94
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL

https://www.onclive.com/common.js

Requested by

Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

52.206.141.94 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),

Reverse DNS

ec2-52-206-141-94.compute-1.amazonaws.com

Software

Apache/2.4.7 (Ubuntu) /

Resource Hash

e4f8b372ea9d98bec0d37ca1dd58a98b5c144c22631db665b10e39a48ec02cff

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:15 GMT
content-encoding: gzip
last-modified: Tue, 15 Oct 2019 20:56:04 GMT
server: Apache/2.4.7 (Ubuntu)
etag: "132e-594f9366a7e43-gzip"
vary: Accept-Encoding
content-type: application/javascript
status: 200
content-security-policy: upgrade-insecure-requests
accept-ranges: bytes
content-length: 1039

GET
H2 200 iframeResizer.min.js Show response
www.onclive.com/ 13 KB
5 KB 183ms
180ms Script
application/javascript 52.206.141.94
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL

https://www.onclive.com/iframeResizer.min.js

Requested by

Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

52.206.141.94 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),

Reverse DNS

ec2-52-206-141-94.compute-1.amazonaws.com

Software

Apache/2.4.7 (Ubuntu) /

Resource Hash

88142d9f432733e35dae2b2f0a1373b01a09966419adbdd28227ca2305fd118d

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:15 GMT
content-encoding: gzip
last-modified: Tue, 15 Oct 2019 20:56:04 GMT
server: Apache/2.4.7 (Ubuntu)
etag: "3320-594f9366c4f63-gzip"
vary: Accept-Encoding
content-type: application/javascript
status: 200
content-security-policy: upgrade-insecure-requests
accept-ranges: bytes
content-length: 5183

GET
H2 200 global.css
www.onclive.com/_css/ 1 KB
785 B 106ms
104ms Stylesheet
text/css 52.206.141.94
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL

https://www.onclive.com/_css/global.css

Requested by

Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

52.206.141.94 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),

Reverse DNS

ec2-52-206-141-94.compute-1.amazonaws.com

Software

Apache/2.4.7 (Ubuntu) /

Resource Hash

1d5c94790ddde358acd7bf7fc16d42668959209d8b5eafca745ecc1b19dad4b1

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:14 GMT
content-encoding: gzip
last-modified: Tue, 15 Oct 2019 20:56:04 GMT
server: Apache/2.4.7 (Ubuntu)
etag: "588-594f9366a2083-gzip"
vary: Accept-Encoding
content-type: text/css
status: 200
content-security-policy: upgrade-insecure-requests
accept-ranges: bytes
content-length: 548

GET
H2 200 css.css
www.onclive.com/_css/ 38 KB
9 KB 195ms
194ms Stylesheet
text/css 52.206.141.94
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL

https://www.onclive.com/_css/css.css?v=9.59

Requested by

Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

52.206.141.94 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),

Reverse DNS

ec2-52-206-141-94.compute-1.amazonaws.com

Software

Apache/2.4.7 (Ubuntu) /

Resource Hash

bb0a0fd3a538d35260b2a6717b6df74668aa661c881e23be91d393bc06f7b2ed

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:14 GMT
content-encoding: gzip
last-modified: Tue, 15 Oct 2019 20:56:04 GMT
server: Apache/2.4.7 (Ubuntu)
etag: "989f-594f9366ae808-gzip"
vary: Accept-Encoding
content-type: text/css
status: 200
content-security-policy: upgrade-insecure-requests
accept-ranges: bytes
content-length: 9293

GET
H2 200 forum.css
www.onclive.com/ 8 KB
2 KB 194ms
193ms Stylesheet
text/css 52.206.141.94
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL

https://www.onclive.com/forum.css

Requested by

Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

52.206.141.94 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),

Reverse DNS

ec2-52-206-141-94.compute-1.amazonaws.com

Software

Apache/2.4.7 (Ubuntu) /

Resource Hash

1a3f9e3900670fa264a64557d5a34623cff455bb4562410d4f414864732763b4

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:14 GMT
content-encoding: gzip
last-modified: Tue, 15 Oct 2019 20:56:04 GMT
server: Apache/2.4.7 (Ubuntu)
etag: "21d5-594f9366bc662-gzip"
vary: Accept-Encoding
content-type: text/css
status: 200
content-security-policy: upgrade-insecure-requests
accept-ranges: bytes
content-length: 2134

GET
H2 200 gating.css
www.onclive.com/_css/ 666 B
573 B 192ms
191ms Stylesheet
text/css 52.206.141.94
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL

https://www.onclive.com/_css/gating.css

Requested by

Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

52.206.141.94 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),

Reverse DNS

ec2-52-206-141-94.compute-1.amazonaws.com

Software

Apache/2.4.7 (Ubuntu) /

Resource Hash

f70f05b96c323cf2a690ea2104699203a5fdfd1ea9cdff906e44e622ddfca970

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:14 GMT
content-encoding: gzip
last-modified: Tue, 15 Oct 2019 20:56:04 GMT
server: Apache/2.4.7 (Ubuntu)
etag: "29a-594f9366af7a7-gzip"
vary: Accept-Encoding
content-type: text/css
status: 200
content-security-policy: upgrade-insecure-requests
accept-ranges: bytes
content-length: 336

GET
H2 200 gate.css
www.onclive.com/_css/ 1 KB
763 B 197ms
196ms Stylesheet
text/css 52.206.141.94
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL

https://www.onclive.com/_css/gate.css?v=1

Requested by

Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

52.206.141.94 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),

Reverse DNS

ec2-52-206-141-94.compute-1.amazonaws.com

Software

Apache/2.4.7 (Ubuntu) /

Resource Hash

9678fd1a4082dd01da0ea1fc2a25ba3309bd766936a77584b8a7000dbd071b22

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:14 GMT
content-encoding: gzip
last-modified: Tue, 15 Oct 2019 20:56:04 GMT
server: Apache/2.4.7 (Ubuntu)
etag: "5cf-594f9366a2083-gzip"
vary: Accept-Encoding
content-type: text/css
status: 200
content-security-policy: upgrade-insecure-requests
accept-ranges: bytes
content-length: 526

GET
H2 200 main.min.js Show response
lucid.mjhassoc.com/_js/ 3 KB
2 KB 114ms
99ms Script
application/javascript 52.20.98.150
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://lucid.mjhassoc.com/_js/main.min.js?v=1.123
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.20.98.150 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-52-20-98-150.compute-1.amazonaws.com
Software: Apache/2.4.7 (Ubuntu) /
Resource Hash: 3245b573f07b5ad374ec27d28fce9431e7e3004f6a246f11c528059979973a2d

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:15 GMT
content-encoding: gzip
last-modified: Thu, 17 Oct 2019 18:12:49 GMT
server: Apache/2.4.7 (Ubuntu)
etag: "cd7-5951f2a47035c-gzip"
vary: Accept-Encoding
content-type: application/javascript
status: 200
accept-ranges: bytes
content-length: 1424

GET
H2 200 sharing-sheep.min.css
lucid.mjhassoc.com/_css/ 3 KB
810 B 326ms
100ms Stylesheet
text/css 52.20.98.150
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://lucid.mjhassoc.com/_css/sharing-sheep.min.css?v=1.123
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.20.98.150 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-52-20-98-150.compute-1.amazonaws.com
Software: Apache/2.4.7 (Ubuntu) /
Resource Hash: aad74e3fb3cf9a8095dd4f9cf3e3d7e01bc3fbf7651dc64a9372b52cd38a61d3

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:15 GMT
content-encoding: gzip
last-modified: Thu, 17 Oct 2019 18:12:49 GMT
server: Apache/2.4.7 (Ubuntu)
etag: "b35-5951f2a46f3bc-gzip"
vary: Accept-Encoding
content-type: text/css
status: 200
accept-ranges: bytes
content-length: 610

GET
H2 200 all.css
use.fontawesome.com/releases/v5.1.0/css/ 45 KB
11 KB 72ms
34ms Stylesheet
text/css 23.111.9.35
Highwinds Network...

General

Check archive.org

Show headers Download Go to

Full URL: https://use.fontawesome.com/releases/v5.1.0/css/all.css
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 23.111.9.35 Phoenix, United States, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
Software: NetDNA-cache/2.2 /
Resource Hash: ce91e2144ea27f82292ef2c87c5d9e1d0b9994df63836130293865aca18fc550

Request headers

Sec-Fetch-Mode: cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Origin: https://www.onclive.com
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:14 GMT
content-encoding: gzip
last-modified: Wed, 20 Jun 2018 20:19:16 GMT
server: NetDNA-cache/2.2
status: 200
etag: W/"826c57385f3d35cfed5478ba7b1f5c03"
vary: Origin, Access-Control-Request-Headers, Access-Control-Request-Method, Accept-Encoding
access-control-allow-methods: GET
content-type: text/css
access-control-allow-origin: *
access-control-max-age: 3000
cache-control: max-age=31556926
x-cache: HIT

GET
H2 200 lucid.min.js Show response
lucid.mjhassoc.com/ 5 KB
2 KB 326ms
99ms Script
application/javascript 52.20.98.150
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://lucid.mjhassoc.com/lucid.min.js?v=1.123
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.20.98.150 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-52-20-98-150.compute-1.amazonaws.com
Software: Apache/2.4.7 (Ubuntu) /
Resource Hash: f43b55d9076122546111325c47530a6ccafc648b65880df2dc855c05fdab6144

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:15 GMT
content-encoding: gzip
last-modified: Thu, 17 Oct 2019 18:12:52 GMT
server: Apache/2.4.7 (Ubuntu)
etag: "1287-5951f2a745cab-gzip"
vary: Accept-Encoding
content-type: application/javascript
status: 200
accept-ranges: bytes
content-length: 1718

GET
H2 200 beam.min.js Show response
lucid.mjhassoc.com/ 10 KB
3 KB 326ms
100ms Script
application/javascript 52.20.98.150
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://lucid.mjhassoc.com/beam.min.js?v=1.123
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.20.98.150 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-52-20-98-150.compute-1.amazonaws.com
Software: Apache/2.4.7 (Ubuntu) /
Resource Hash: ffb885d40de0ddb10d6b8fa4efc0c70e646a79826869487491f52af3c738d2d7

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:15 GMT
content-encoding: gzip
last-modified: Thu, 17 Oct 2019 18:12:51 GMT
server: Apache/2.4.7 (Ubuntu)
etag: "2950-5951f2a626af1-gzip"
vary: Accept-Encoding
content-type: application/javascript
status: 200
accept-ranges: bytes
content-length: 2501

GET
H/1.1 200
OK logo32_onclive.png
onclive.s3.amazonaws.com/_media/_core/ 6 KB
6 KB 2104ms
169ms Image
image/png 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_core/logo32_onclive.png
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: a61b19542e1ab09f562962cc4c89d12794dae7334d631d4002a901786b544e7a

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:18 GMT
Last-Modified: Tue, 26 Sep 2017 13:49:47 GMT
Server: AmazonS3
x-amz-request-id: 76F8E0BA5A5FB6ED
ETag: "c483670fc5ee533aae5ad2ad088a6fa5"
x-amz-meta-cache-control: max-age=86400
x-amz-version-id: uF5__dC6d2D8Kw8o3w7SvqQpvkau8CuM
Cache-Control: max-age=86400
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: image/png
Content-Length: 5775
x-amz-id-2: D1ilhHRFbDvvQDvG7Mm8ofkGn7dqI1yJ9wK3NR8oO27Dhl2wBm/4iPacCjHoSumWQnVnzhIhAmg=
x-amz-meta-s3b-last-modified: 20161123T203053Z

GET
H/1.1 200
OK search_button.png
onclive.s3.amazonaws.com/_media/_core/ 3 KB
4 KB 2171ms
139ms Image
binary/octet-stream 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_core/search_button.png
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: 3dbb50e7141948b08d6d3b6d747e3d596ca37499a006e8b7b9a49f5447318257

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:18 GMT
Last-Modified: Tue, 26 Sep 2017 13:49:49 GMT
Server: AmazonS3
x-amz-meta-s3cmd-attrs: uid:33/gname:satellite/uname:www-data/gid:1003/mode:33272/mtime:1397073200/atime:1418841571/ctime:1405619926
x-amz-request-id: F6C057F2149B3115
ETag: "1227e6beaa3165de430ab9fc2f33bf1d"
x-amz-meta-cache-control: max-age=86400
x-amz-version-id: 4vbjOzsz02kmjv6jy0C8zLcQmTxCzKhu
Cache-Control: max-age=86400
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: binary/octet-stream
Content-Length: 3162
x-amz-id-2: +3FXYN1hrlHeVfcKkKeqOTV/lQBsCygUYxHKCRoQqVLtV3lfuq+SVAmzAOqnjrIW8g0nRhygLG0=
Expires: Thu, 20 Jul 2017 02:09:09 GMT

GET
H2 200 jquery.marquee.min.js Show response
cdn.jsdelivr.net/jquery.marquee/1.4.0/ 6 KB
2 KB 19ms
5ms Script
application/javascript 2a04:4e42:1b::621
Fastly

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.jsdelivr.net/jquery.marquee/1.4.0/jquery.marquee.min.js

Requested by

Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

2a04:4e42:1b::621 , Ascension Island, ASN54113 (FASTLY - Fastly, US),

Reverse DNS

Software

Resource Hash

2278cada41d2bcc06dfa905b1e859133291c58dc7fb209a57f9f5d02c11a92e5

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
x-content-type-options: nosniff
x-cache: HIT, HIT
status: 200
content-length: 2004
etag: W/"1606-H/ZiGK7LO21Ah1cIOjYq5Am4CNQ"
x-served-by: cache-ams21025-AMS, cache-hhn4038-HHN
date: Fri, 18 Oct 2019 15:03:14 GMT
vary: Accept-Encoding
content-type: application/javascript; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: public, max-age=31536000, s-maxage=31536000, immutable
accept-ranges: bytes
timing-allow-origin: *

GET
H/1.1

200
OK

Michael_Untch_thumb_new.jpg
onclive.s3.amazonaws.com/_media/_upload_image/
Redirect Chain

https://www.onclive.com/_media/_upload_image/Michael_Untch_thumb_new.jpg
https://onclive.s3.amazonaws.com/_media/_upload_image/Michael_Untch_thumb_new.jpg

29 KB
30 KB

2330ms
112ms

Image
image/jpeg

52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_upload_image/Michael_Untch_thumb_new.jpg
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: e41508e125da1e3d3cdd54deda1399a9381f07e1ea586e7c24e00c15246400c3

Request headers

Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:18 GMT
Last-Modified: Mon, 14 Oct 2019 18:24:45 GMT
Server: AmazonS3
x-amz-request-id: C25A364318C437A3
ETag: "9d2785e80534e8652a7ee7f377dafe2e"
x-amz-version-id: oUnM5vq9RkwN8N0PXGOXJbcwMsmDGQCz
Cache-Control: max-age=2592000
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: image/jpeg
Content-Length: 29878
x-amz-id-2: IdLVMhzLTewCEsbxwd2rpFFOsLj6TkSSmSpm5vG3zseQDDEE8fGvA0QRcfnY1tiCgqw6JQUUGQo=

Redirect headers

status: 301
date: Fri, 18 Oct 2019 15:03:15 GMT
server: Apache/2.4.7 (Ubuntu)
content-length: 370
location: https://onclive.s3.amazonaws.com/_media/_upload_image/Michael_Untch_thumb_new.jpg
content-type: text/html; charset=iso-8859-1

GET
H/1.1

200
OK

Remens_thumb_small_new.jpg
onclive.s3.amazonaws.com/_media/_upload_image/
Redirect Chain

https://www.onclive.com/_media/_upload_image/Remens_thumb_small_new.jpg
https://onclive.s3.amazonaws.com/_media/_upload_image/Remens_thumb_small_new.jpg

27 KB
28 KB

2454ms
130ms

Image
image/jpeg

52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_upload_image/Remens_thumb_small_new.jpg
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: d66f6713b5eb392c41aead08b2b678332ff3b598b9dd8dc9e6004c2962dc95b8

Request headers

Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:18 GMT
Last-Modified: Thu, 06 Dec 2018 13:50:27 GMT
Server: AmazonS3
x-amz-request-id: 6D65873139BFF9F5
ETag: "3584c723afacf0eff2ed2b472497828c"
x-amz-version-id: SpyPj_byRXNwkPXGM4cAl53qqchlUKa1
Cache-Control: max-age=2592000
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: image/jpeg
Content-Length: 27886
x-amz-id-2: NswFGyBkFDBx/3wEJdFDQDv+DqA2OXdNd9CYhUV1sw0e+Z1oFUFZ+XhS3K/vMofC9Gwwwf8LL3Q=

Redirect headers

status: 301
date: Fri, 18 Oct 2019 15:03:15 GMT
server: Apache/2.4.7 (Ubuntu)
content-length: 369
location: https://onclive.s3.amazonaws.com/_media/_upload_image/Remens_thumb_small_new.jpg
content-type: text/html; charset=iso-8859-1

GET
H/1.1

200
OK

C-Kent-Osborne-new-small-thumb.jpg
onclive.s3.amazonaws.com/_media/_upload_image/
Redirect Chain

https://www.onclive.com/_media/_upload_image/C-Kent-Osborne-new-small-thumb.jpg
https://onclive.s3.amazonaws.com/_media/_upload_image/C-Kent-Osborne-new-small-thumb.jpg

46 KB
47 KB

2402ms
130ms

Image
image/jpeg

52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_upload_image/C-Kent-Osborne-new-small-thumb.jpg
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: 922dcde89e79b3f3e49a2534b5fffcdbae76a2b7b40e7843db079076c4b21ec2

Request headers

Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:18 GMT
Last-Modified: Tue, 26 Sep 2017 14:24:26 GMT
Server: AmazonS3
x-amz-request-id: 62DF83F45AC37ED1
ETag: "448cab34fa4a5885538ebf530c749c8b"
x-amz-meta-cache-control: max-age=86400
x-amz-version-id: l9dLSaGrl2eWZMqGXQ1hcWV7lLG1Xvoo
Cache-Control: max-age=86400
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: image/jpeg
Content-Length: 47170
x-amz-id-2: V5g+rGW4uRZFvIM19FnrVy6baDi7AjnS7kVIttyETyOrUo0eTxBaylqYkGz6btQT5MrpjDJ7Nwc=

Redirect headers

status: 301
date: Fri, 18 Oct 2019 15:03:15 GMT
server: Apache/2.4.7 (Ubuntu)
content-length: 377
location: https://onclive.s3.amazonaws.com/_media/_upload_image/C-Kent-Osborne-new-small-thumb.jpg
content-type: text/html; charset=iso-8859-1

GET
H/1.1

200
OK

Anders_website_128.jpg
onclive.s3.amazonaws.com/_media/_upload_image/
Redirect Chain

https://www.onclive.com/_media/_upload_image/Anders_website_128.jpg
https://onclive.s3.amazonaws.com/_media/_upload_image/Anders_website_128.jpg

68 KB
69 KB

1942ms
331ms

Image
image/jpeg

52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_upload_image/Anders_website_128.jpg
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: 950e3404d511a01e295de4c1c43599406bd30d344851d03fe399de21e6fbb3a7

Request headers

Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:18 GMT
Last-Modified: Thu, 17 Oct 2019 17:45:45 GMT
Server: AmazonS3
x-amz-request-id: A5B797585FF67A34
ETag: "8214a085c2e12b9e3d48678868cac49f"
x-amz-version-id: NtFnP1j9k7ofSvwg7HdyMINkfBpUKtkK
Cache-Control: max-age=2592000
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: image/jpeg
Content-Length: 69791
x-amz-id-2: PZAjdR5rIBUmxZJa8SvjOUnTvXcVJXT1+NELaKFGSLWQ0330r2GxOWlsW59ydyeq7YOYkldGVlY=

Redirect headers

status: 301
date: Fri, 18 Oct 2019 15:03:15 GMT
server: Apache/2.4.7 (Ubuntu)
content-length: 365
location: https://onclive.s3.amazonaws.com/_media/_upload_image/Anders_website_128.jpg
content-type: text/html; charset=iso-8859-1

GET
H/1.1

200
OK

Bhave_website_136.jpg
onclive.s3.amazonaws.com/_media/_upload_image/
Redirect Chain

https://www.onclive.com/_media/_upload_image/Bhave_website_136.jpg
https://onclive.s3.amazonaws.com/_media/_upload_image/Bhave_website_136.jpg

67 KB
67 KB

1733ms
109ms

Image
image/jpeg

52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_upload_image/Bhave_website_136.jpg
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: 960e3932849f47996993dece531279d1abb554d2ff02dcc669c15a7e0027b5c3

Request headers

Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:18 GMT
Last-Modified: Tue, 15 Oct 2019 19:28:28 GMT
Server: AmazonS3
x-amz-request-id: 9B4D4BCB264023D7
ETag: "7419f670ed22505c8792a0c371059058"
x-amz-version-id: y4vBDLLZHltFJ9RaVQvvjHgoarKXI3v5
Cache-Control: max-age=2592000
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: image/jpeg
Content-Length: 68528
x-amz-id-2: /1SV7/MH/YdCe6061gcpJ+ZeBoqeVPAqWw43VJ+dTjwh3eGGFjXexUw9soZujipdgfWEMihJY7I=

Redirect headers

status: 301
date: Fri, 18 Oct 2019 15:03:15 GMT
server: Apache/2.4.7 (Ubuntu)
content-length: 364
location: https://onclive.s3.amazonaws.com/_media/_upload_image/Bhave_website_136.jpg
content-type: text/html; charset=iso-8859-1

GET
H/1.1

200
OK

Kelly_Westbrook_10.9.19-video-thumb.jpg
onclive.s3.amazonaws.com/_media/_upload_image/
Redirect Chain

https://www.onclive.com/_media/_upload_image/Kelly_Westbrook_10.9.19-video-thumb.jpg
https://onclive.s3.amazonaws.com/_media/_upload_image/Kelly_Westbrook_10.9.19-video-thumb.jpg

38 KB
38 KB

2443ms
108ms

Image
image/jpeg

52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_upload_image/Kelly_Westbrook_10.9.19-video-thumb.jpg
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: 6489c348b002668f2929f770545687eac8adf035586e056a38a8fa602808d8d1

Request headers

Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:18 GMT
Last-Modified: Wed, 09 Oct 2019 16:42:00 GMT
Server: AmazonS3
x-amz-request-id: 98EE7E455CD833BF
ETag: "05f371978aab1fd5d5f31de853867218"
x-amz-version-id: O1govgzL3jG1ABHl_O8UDx8D57WfjYMV
Cache-Control: max-age=2592000
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: image/jpeg
Content-Length: 38618
x-amz-id-2: Zqn+93YWpoI4lCFIKYUjBqP9Drm3a74ypokC8wlMLdYfnNmaI49CHK/jLkQvVCod7od1chUUHVI=

Redirect headers

status: 301
date: Fri, 18 Oct 2019 15:03:15 GMT
server: Apache/2.4.7 (Ubuntu)
content-length: 382
location: https://onclive.s3.amazonaws.com/_media/_upload_image/Kelly_Westbrook_10.9.19-video-thumb.jpg
content-type: text/html; charset=iso-8859-1

GET
H2 200 buttons.js Show response
ws.sharethis.com/button/ 55 KB
16 KB 24ms
10ms Script
application/javascript 2600:9000:21f3:6200:3:c04e:c780:93a1
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://ws.sharethis.com/button/buttons.js
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 2600:9000:21f3:6200:3:c04e:c780:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software: nginx/1.12.2 /
Resource Hash: 011af481a6c21ebe9524e49d785ca76479a7f44c63e013848d2992cba4e12532

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Sat, 12 Oct 2019 23:57:31 GMT
content-encoding: gzip
server: nginx/1.12.2
age: 227137
etag: "5d9e5f01-dd87"
vary: Accept-Encoding
x-cache: Hit from cloudfront
content-type: application/javascript
status: 200
cache-control: max-age=259200
x-amz-cf-pop: FRA2-C2
x-robots-tag: noindex, nofollow
x-amz-cf-id: 5oYBLCyXiZ5QMM1QVwiVlVLhRh6dvEuuWbidBoG3K4cD1dR_eua2Ag==
via: 1.1 56fad5a50ef67bd961b9722ed0931839.cloudfront.net (CloudFront)
expires: Tue, 15 Oct 2019 23:57:31 GMT

GET
H/1.1 200
OK printButton.png
s3.amazonaws.com/hcplive/v1_media/_image/ 4 KB
4 KB 533ms
237ms Image
binary/octet-stream 52.216.164.101
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://s3.amazonaws.com/hcplive/v1_media/_image/printButton.png
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.164.101 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software: AmazonS3 /
Resource Hash: 12f22cf81b4ffd0cb4a8c8fb8d0cf4eb4305174f3c116b9c2d94959bc8114496

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:16 GMT
Last-Modified: Tue, 26 Sep 2017 13:17:30 GMT
Server: AmazonS3
x-amz-request-id: A51AC4347E80FD12
ETag: "7aaeac9442d224005e3dc844cd5f9016"
x-amz-meta-cache-control: max-age=86400
x-amz-version-id: W01Lv_koBKlkRmIkisKEVJQhEon1cfJj
Cache-Control: max-age=86400
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: binary/octet-stream
Content-Length: 4011
x-amz-id-2: qVezf6S1RQsjKJ81nLXvJ010Udf2PBoolzE0st/FPkDkb7Cf/fUhTKCL8rEg6X3X3TTdmmNFoZo=

GET
H/1.1 200
OK Jose_Baselga_headshot.jpg
s3.amazonaws.com/onclive/_media/_upload_image/ 37 KB
37 KB 469ms
141ms Image
image/jpeg 52.216.164.101
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://s3.amazonaws.com/onclive/_media/_upload_image/Jose_Baselga_headshot.jpg
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.164.101 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software: AmazonS3 /
Resource Hash: 4e0541f2eabded13a1a1090eaf4ae5c8c072e4c3bf2b61ef3708796b3621624a

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:16 GMT
Last-Modified: Tue, 07 May 2019 18:09:08 GMT
Server: AmazonS3
x-amz-request-id: 848838B9AEDA2877
ETag: "3219020b47c5167629f55a6043d2369a"
x-amz-version-id: mamkG3ozMtwXBVNtBRVDh1ULU8kR17Y5
Cache-Control: max-age=2592000
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: image/jpeg
Content-Length: 37720
x-amz-id-2: JxS5Di3aAfjW7yoLw4oZDq+klXyunRqZeFzD50cCIbXGkpOqfBEB7X63GxhAMYAdYMr5jpTBOKA=

GET
H2 200 gtm.js Show response
www.googletagmanager.com/ 99 KB
33 KB 17ms
15ms Script
application/javascript 2a00:1450:4001:81a::2008
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagmanager.com/gtm.js?id=GTM-W2MSXQC

Requested by

Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:81a::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

Google Tag Manager /

Resource Hash

ac727f7d4aa3a53fdb0ff12526803e06482df768af5a834f3769ef197e4b337c

Security Headers

Name	Value
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:15 GMT
content-encoding: br
server: Google Tag Manager
access-control-allow-headers: Cache-Control
status: 200
vary: Accept-Encoding
content-type: application/javascript; charset=UTF-8
access-control-allow-origin: http://www.googletagmanager.com
cache-control: private, max-age=900
access-control-allow-credentials: true
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 33850
x-xss-protection: 0
expires: Fri, 18 Oct 2019 15:03:15 GMT

GET
H2 200 jquery.bxslider.js Show response
www.onclive.com/_js/bxslider/ 19 KB
5 KB 103ms
103ms Script
application/javascript 52.206.141.94
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL

https://www.onclive.com/_js/bxslider/jquery.bxslider.js

Requested by

Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

52.206.141.94 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),

Reverse DNS

ec2-52-206-141-94.compute-1.amazonaws.com

Software

Apache/2.4.7 (Ubuntu) /

Resource Hash

bb9e7dc822c6b7b95a6329932885c72ff2caf74b243fc1c40aca0e858123b83e

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:15 GMT
content-encoding: gzip
last-modified: Tue, 15 Oct 2019 20:56:04 GMT
server: Apache/2.4.7 (Ubuntu)
etag: "4b9f-594f9366b0747-gzip"
vary: Accept-Encoding
content-type: application/javascript
status: 200
content-security-policy: upgrade-insecure-requests
accept-ranges: bytes
content-length: 5162

GET
H2 200 jquery.bxslider.css
www.onclive.com/_js/bxslider/ 4 KB
1 KB 127ms
127ms Stylesheet
text/css 52.206.141.94
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL

https://www.onclive.com/_js/bxslider/jquery.bxslider.css

Requested by

Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

52.206.141.94 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),

Reverse DNS

ec2-52-206-141-94.compute-1.amazonaws.com

Software

Apache/2.4.7 (Ubuntu) /

Resource Hash

a927b76b903465214e3b297bfc9df32efa23d58d012d394c36bee7f65f7f37bc

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:15 GMT
content-encoding: gzip
last-modified: Tue, 15 Oct 2019 20:56:04 GMT
server: Apache/2.4.7 (Ubuntu)
etag: "eaf-594f9366a6ea3-gzip"
vary: Accept-Encoding
content-type: text/css
status: 200
content-security-policy: upgrade-insecure-requests
accept-ranges: bytes
content-length: 1169

GET
H/1.1 200
OK sapSeal_right.png
onclive.s3.amazonaws.com/_media/_core/ 36 KB
37 KB 2248ms
144ms Image
binary/octet-stream 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_core/sapSeal_right.png
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: e1b45346f29f4a31a6e0789cbe6e1fc9c624774135b1920944b1f8eb65fa251c

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:18 GMT
Last-Modified: Tue, 26 Sep 2017 13:49:50 GMT
Server: AmazonS3
x-amz-request-id: A9AC14DA93D665C4
ETag: "6d1885ec232ee6b9dc63929a7b13abbe"
x-amz-meta-cache-control: max-age=86400
x-amz-version-id: u4pYj11MS8OHfTXhZ8isoaduVwGbHW8v
Cache-Control: max-age=86400
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: binary/octet-stream
Content-Length: 37084
x-amz-id-2: tdS0cvGmjSElR+mdSUMWLBt72DCIkcdPcXy1xp4Jtj5+kb6OoOlfiYpYqs7Mpb4x31Vt6PeuzR4=
Expires: Thu, 20 Jul 2017 02:09:09 GMT

GET
H/1.1 200
OK pubSliderBT.png
onclive.s3.amazonaws.com/_media/_core/ 7 KB
8 KB 2281ms
128ms Image
binary/octet-stream 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_core/pubSliderBT.png
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: 30a48656491a23cf70d367c142e3089eff7c31214eb74484e92d144ea60db378

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:18 GMT
Last-Modified: Tue, 26 Sep 2017 13:49:49 GMT
Server: AmazonS3
x-amz-request-id: 790185F1AD3F458D
ETag: "3d8844f4dd176527ff6bb906aa2ee2de"
x-amz-meta-cache-control: max-age=86400
x-amz-version-id: QGSF7e9_9whszk1CmvMCXsNnDHJD4DPX
Cache-Control: max-age=86400
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: binary/octet-stream
Content-Length: 7533
x-amz-id-2: SFIVwShbnA8N/DW17gbP1cj1XHrM1Pi7nnyPuVgEtUD2rB9EMJlUhtOuc2BVd5pTz08WWwCMops=
Expires: Thu, 20 Jul 2017 02:09:09 GMT

GET
H/1.1 200
OK DermatologistsInCancerCare.jpg
onclive.s3.amazonaws.com/_media/_issue/ 330 KB
330 KB 2284ms
113ms Image
image/jpeg 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_issue/DermatologistsInCancerCare.jpg
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: 81cbdefb357fa01ec876f6bc283323270b2ac96192115d3ce8e3c11571efcc2b

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:18 GMT
Last-Modified: Fri, 13 Jul 2018 17:37:30 GMT
Server: AmazonS3
x-amz-request-id: 58E12BFE13A936AB
ETag: "5a7e0bee29a4760a1eb251b549d485da"
x-amz-version-id: WfGUmiTT2wxSHutAke7acodeMbjOmd__
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: image/jpeg
Content-Length: 337785
x-amz-id-2: Q3XdkplmlIx8RGJm5Dfxy23WkGYbi5pJowfOE9cp0UrTKpMI7U6kkIZ0UruZcvxaieDwBQaDrXM=
x-amz-meta-s3b-last-modified: 20180713T172733Z

GET
H/1.1 200
OK Milestones_Cover.jpg
onclive.s3.amazonaws.com/_media/_issue/ 139 KB
140 KB 2395ms
113ms Image
image/jpeg 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_issue/Milestones_Cover.jpg
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: 3b2d719312c2cff015b7ab28dae7d2b796b0cf9a0602b65d6b80b43c99eba4b7

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:18 GMT
Last-Modified: Mon, 18 Feb 2019 20:53:58 GMT
Server: AmazonS3
x-amz-request-id: C040ACC443886401
ETag: "379d35b122220f3e47e4ba5ebe217714"
x-amz-version-id: 8N4GmRR..fpe0J3ee3IhrFIXETSnu.4X
Cache-Control: max-age=2592000
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: image/jpeg
Content-Length: 142634
x-amz-id-2: c3itu7l7+2gvM+jHDmYmCI7wvK1oSv7breh/cuoVS1HQH8H+CggV+9dfpuHtLx84hm7vkBCYQP4=

GET
H/1.1 200
OK OG365_HCL%20Priority%20Report%20Cover%20Image.JPG
onclive.s3.amazonaws.com/_media/_issue/ 65 KB
66 KB 543ms
113ms Image
image/jpeg 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_issue/OG365_HCL%20Priority%20Report%20Cover%20Image.JPG
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: adf393fb74578819d0d9973fae0b30b2f02a922fd45bd3a7967cfaf8ebb7dc7c

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:18 GMT
Last-Modified: Fri, 14 Jun 2019 13:12:08 GMT
Server: AmazonS3
x-amz-request-id: 20E56D46640D17B7
ETag: "d55ec0b83d08add988cd5ce39c149a5f"
x-amz-version-id: .TBL8B6myByYE.xNb6rwsEg9BqjPAYjC
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: image/jpeg
Content-Length: 66806
x-amz-id-2: yowlp+lICA+AImWUdKGkd/JYQE4QHtSxsacqAbWk+wzfx/o2JBDJFdZwFP8/OK6Ht9vaTwDTZkM=

GET
H/1.1 200
OK Pulmonologists_MD_Onc.jpg
onclive.s3.amazonaws.com/_media/_issue/ 1 MB
1 MB 518ms
114ms Image
image/jpeg 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_issue/Pulmonologists_MD_Onc.jpg
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: 527268c694720dd614cd9cf6581e05704f774342f603eac32e9c600b1823123e

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:18 GMT
Last-Modified: Mon, 22 Apr 2019 20:03:29 GMT
Server: AmazonS3
x-amz-request-id: 159B6514433FEFED
ETag: "0deffbcb799d90bf48de0b87cb6ddf8f"
x-amz-version-id: HK_EvWqVs9StekhU2_EKVAe2H3vn6xOT
Cache-Control: max-age=2592000
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: image/jpeg
Content-Length: 1075457
x-amz-id-2: 2Hxk+mP39YDrxP/g7tHrhxgidVNxuzr1qQoxlARaX6/CwBhIHWFI3QH4SHB9Rf56m+Ot5L239iA=

GET
H/1.1 200
OK RapidReporter_Thumbnail_081419v1.jpg
onclive.s3.amazonaws.com/_media/_issue/ 3 MB
3 MB 421ms
112ms Image
image/jpeg 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_issue/RapidReporter_Thumbnail_081419v1.jpg
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: 2fdeb143ead5283cb458e5bf05d04517da39c6581294ca42de400963cbbe7279

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:18 GMT
Last-Modified: Thu, 15 Aug 2019 16:45:16 GMT
Server: AmazonS3
x-amz-request-id: 6BB1A79F2F96ED59
ETag: "b093e9dee1c08b8acfdea4b2450dc530"
x-amz-version-id: oWa2XMDD2gG5Sq1lDyljH0Qp2quwXhpp
Cache-Control: max-age=2592000
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: image/jpeg
Content-Length: 2970541
x-amz-id-2: cChuZ7JwoBY1HMK2FSS2pIr5TYG3QmBvezg+r5haQVUZoL9izyfPHWJA2UlN7h5+E5WmK9C2BgA=

GET
H/1.1 200
OK RapidReviewsInOncology.jpg
onclive.s3.amazonaws.com/_media/_issue/ 323 KB
323 KB 425ms
112ms Image
image/jpeg 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_issue/RapidReviewsInOncology.jpg
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: aac178622d40bd5b38b35919d70ed3c35823727cdd27761a89e80920d15bd1a3

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:18 GMT
Last-Modified: Wed, 18 Jul 2018 15:53:47 GMT
Server: AmazonS3
x-amz-request-id: 6BC5FF0C6753CA21
ETag: "bd48181d84058a41ae249ea913faa9f6"
x-amz-version-id: y4omdWOLp6JCSUDrJ55poWZIIhqNXt6K
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: image/jpeg
Content-Length: 330302
x-amz-id-2: zxhtyxBbLlIueLHIQwVxsAxwP0QpLz/NuK0L3ex64KzczGsYZ120UOEE5XWl5vbn504aPsEf7KM=
x-amz-meta-s3b-last-modified: 20180718T153318Z

GET
H/1.1 200
OK OL_October1cover2019.jpg
onclive.s3.amazonaws.com/_media/_issue/ 313 KB
314 KB 565ms
113ms Image
image/jpeg 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_issue/OL_October1cover2019.jpg
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: 18d3b8575ac9a4e11afa11f038ee2ee79cc7f28de9e791eeaa5293c78e3b2bee

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:19 GMT
Last-Modified: Tue, 01 Oct 2019 14:03:39 GMT
Server: AmazonS3
x-amz-request-id: FC94686049CE3B49
ETag: "ed555efba4e5539242046799e280ff44"
x-amz-version-id: v8INwXP1Re7Iwdo.lR9euV6bLl7jwm4m
Cache-Control: max-age=2592000
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: image/jpeg
Content-Length: 320921
x-amz-id-2: HtoOWnlDbhR0HQ4l5NbCpGRoASTCnM5yJqpPNxSHkgB3u1sPxJU4PwIW9jZTr5TDN8L9H/j7OrU=

GET
H/1.1 200
OK AugustUCC_2019_coevr.jpg
onclive.s3.amazonaws.com/_media/_issue/ 1 MB
1 MB 517ms
112ms Image
image/jpeg 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_issue/AugustUCC_2019_coevr.jpg
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: b9fce9e3485c32665b2d032874ab76bf7cb3b4710e3dd9a35a214909e2bcb0cb

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:19 GMT
Last-Modified: Mon, 12 Aug 2019 16:10:38 GMT
Server: AmazonS3
x-amz-request-id: 38C52DF92D9BF6A8
ETag: "ef3b8dcf3b5ac9a4bfe1397e48052f92"
x-amz-version-id: S9YPCAaA0UWlCXB6Pa1.MNIx9o3z70g1
Cache-Control: max-age=2592000
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: image/jpeg
Content-Length: 1333239
x-amz-id-2: NVg/arBaMUfcWzxF6IaFbX1OFuo62vWBRaf6vrevH/Y3VHP66b1ZFxVP6UKZiRRABg2CVgeOilg=

GET
H/1.1 200
OK OncologyBusinessNews_TM_Maintenance_04_2018.jpg
onclive.s3.amazonaws.com/_media/_issue/ 982 KB
982 KB 443ms
114ms Image
image/jpeg 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_issue/OncologyBusinessNews_TM_Maintenance_04_2018.jpg
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: 0b95d1768f7b776624af9543a27eeb602a468059bbbcdb2a948ea480b127b730

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:19 GMT
Last-Modified: Fri, 06 Apr 2018 14:15:43 GMT
Server: AmazonS3
x-amz-request-id: 7A12CBDEB1EAC872
ETag: "fa28b25546b2751dae75aa8971f9ad6f"
x-amz-version-id: CkIvVkcI.mBFnV.aF0tkXIEoKzjRf2TI
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: image/jpeg
Content-Length: 1005428
x-amz-id-2: Mo+HspH2ri8u8zztkwsYWmkbYI5VN4OGPMRG93inhqQU9GilvDB/Sn+sk5rWlpviDoHsEfS3tA8=
x-amz-meta-s3b-last-modified: 20180406T140539Z

GET
H/1.1 200
OK CRO-916-16.jpg
onclive.s3.amazonaws.com/_media/_issue/ 12 KB
12 KB 442ms
125ms Image
image/jpeg 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_issue/CRO-916-16.jpg
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: c5abebbacbbce0cbe1b3070c636325dc23db9b320d728e033dc6ea3c18f22265

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:19 GMT
Last-Modified: Tue, 26 Sep 2017 13:54:52 GMT
Server: AmazonS3
x-amz-request-id: A0F80A4BB96F0046
ETag: "9dcdd158d83e7c043a2908b5913c11db"
x-amz-meta-cache-control: max-age=86400
x-amz-version-id: EJjNGAAxBZVNDfu4zMStOioguMGVhEC9
Cache-Control: max-age=86400
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: image/jpeg
Content-Length: 12072
x-amz-id-2: lUFutC6Id9ic24H2nzOzXUVWIlcF4pWcsanFje6mYa72HPJoVwzYD3sPN+w8YzLE3KkbI4zlwuI=

GET
H/1.1 200
OK ONGN_Cover_250x300.jpg
onclive.s3.amazonaws.com/_media/_issue/ 92 KB
93 KB 429ms
114ms Image
image/jpeg 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_issue/ONGN_Cover_250x300.jpg
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: 7cd79c98d2cdc6e4074b9445378ac24deb9483c9bfd329fdd64759f137d354f4

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:19 GMT
Last-Modified: Thu, 21 Dec 2017 14:49:44 GMT
Server: AmazonS3
x-amz-request-id: D996C58F3C9B89BA
ETag: "8f04f32ac74c16b4fc85b203fc7cafeb"
x-amz-version-id: MsD7DOQvO589UHjJ_80heTTYg1k3Umko
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: image/jpeg
Content-Length: 94367
x-amz-id-2: aaxxV3X4HtqCcZ3II+pAlaQvI6QRrEsXm6s1OgqzZSUmcEIln76M+EpkaXLHrBUwqJXs4q/g8F4=

GET
H/1.1 200
OK OncFellows_Sept19_Cover.jpg
onclive.s3.amazonaws.com/_media/_issue/ 274 KB
275 KB 455ms
136ms Image
image/jpeg 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_issue/OncFellows_Sept19_Cover.jpg
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: 18f30f0e76db539f6b10cc8403a72874d895d72ab92954478a98ceeced54d065

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:19 GMT
Last-Modified: Wed, 28 Aug 2019 17:36:40 GMT
Server: AmazonS3
x-amz-request-id: E6F1EDA9F78981C3
ETag: "b272b9a1c501e04f1fd0bc58e4f16587"
x-amz-version-id: ybFC_Em1gf8fau6mqN3yBHuP05bjESem
Cache-Control: max-age=2592000
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: image/jpeg
Content-Length: 280828
x-amz-id-2: pC2mq+XfiGkbO+YFyElDVqBBJ3/3esmCYE3BCEihb9hp6sz9D1VloPR9nVUqLTM+XNuz+Xx2NNI=

GET
H/1.1 200
OK Pub-Covers216.jpg
onclive.s3.amazonaws.com/_media/_issue/ 13 KB
14 KB 254ms
121ms Image
binary/octet-stream 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_issue/Pub-Covers216.jpg
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: 744fa095e7775f605ca798fe37719a646947c4d0f5854f0aa2dc0c029820262c

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:19 GMT
Last-Modified: Tue, 26 Sep 2017 13:55:18 GMT
Server: AmazonS3
x-amz-request-id: 80A3E0ED5A82E8B9
ETag: "933ef2073f3c95fa69d3e8e380e9d571"
x-amz-meta-cache-control: max-age=86400
x-amz-version-id: TkpZCESh36CEjgZNgRA_DTJ8WeWT4WWa
Cache-Control: max-age=86400
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: binary/octet-stream
Content-Length: 13538
x-amz-id-2: LXj+xi5v0dRVM50NSYSdZCsbT/9mmKz4NbnrCyKl/3ymfcE2cpP/sFeznWjrMbz9sOEGrAm3YpQ=

GET
H/1.1 200
OK EmergingMoas.jpg
onclive.s3.amazonaws.com/_media/_issue/ 26 KB
26 KB 348ms
180ms Image
image/jpeg 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_issue/EmergingMoas.jpg
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: ceb31212b9362a4734b5630e9a826c5ab83a44374e72c3e832b4e6579800870d

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:19 GMT
Last-Modified: Mon, 23 Sep 2019 19:20:20 GMT
Server: AmazonS3
x-amz-request-id: 5170E8FD4F9F5506
ETag: "029f480418c5e0d8ba9a61f1a501e894"
x-amz-version-id: ksLF__Nrr.eFBPnE8LJmxrmU9myv.mCy
Cache-Control: max-age=2592000
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: image/jpeg
Content-Length: 26593
x-amz-id-2: GYSy4ix9e/ybXOgJdusg2VIfEwrwFndrdo5glxwVxYuFr8BD7IAoF8D3qw2M31IfSjl4P7WLMv0=

GET
H/1.1 200
OK PeerReviewed-Newsletter-thumbnail.jpg
onclive.s3.amazonaws.com/_media/_issue/ 38 KB
38 KB 212ms
137ms Image
image/jpeg 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_issue/PeerReviewed-Newsletter-thumbnail.jpg
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: b5b5900bd3400a3229d9c40e63b04b81cd0de92be5b3bcd140cba803bf44480a

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:19 GMT
Last-Modified: Tue, 26 Sep 2017 13:55:17 GMT
Server: AmazonS3
x-amz-request-id: F1B495A8CE6438EB
ETag: "b37ed9f9e350190c7dd82630b672a690"
x-amz-meta-cache-control: max-age=86400
x-amz-version-id: jrgdq2D0LqBaiihJWGzb02nwhF766InJ
Cache-Control: max-age=86400
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: image/jpeg
Content-Length: 38789
x-amz-id-2: b1Wr8+yWKWAR3oxHrXba9nZhSPuzZySZoR9xIfoMlMxml2VnESeScvwAfoElzhIDLg/WA+OSfBU=

GET
H/1.1 200
OK OncPathways_06_2018_TrademarkMaintenance.jpg
onclive.s3.amazonaws.com/_media/_issue/ 278 KB
278 KB 216ms
147ms Image
image/jpeg 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_issue/OncPathways_06_2018_TrademarkMaintenance.jpg
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: 60242e5679cef80e50ab7eb43033d08d8f627b8f8205441149ca501553c2640f

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:19 GMT
Last-Modified: Thu, 14 Jun 2018 21:20:12 GMT
Server: AmazonS3
x-amz-request-id: C7C70B2402792ABE
ETag: "3e09cdfd86ae57640139bd1bd584e2d5"
x-amz-version-id: EaImGFb9P1CHWCv7wwJfxhr0aWM86yXn
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: image/jpeg
Content-Length: 284605
x-amz-id-2: JOEtL/+5E/S5yq0ZyZXys5Hj6e+1JitlivlKEtKgeK0lTF2zTlC/nsNrFlHnQ/INXHYdekiZ1EY=
x-amz-meta-s3b-last-modified: 20180614T205516Z

GET
H/1.1 200
OK CURE_Rare_high.jpg
onclive.s3.amazonaws.com/_media/_upload_image/ 13 KB
13 KB 122ms
122ms Image
image/jpeg 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_upload_image/CURE_Rare_high.jpg
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: fac5dbb445547082bd7074d322edcbb27aec8bbb6132f0e7cef0d84e19cca31a

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:19 GMT
Last-Modified: Tue, 26 Sep 2017 14:24:44 GMT
Server: AmazonS3
x-amz-request-id: D8DFBDB780C414DA
ETag: "7549b5b4e4e1a083fcd868270650b317"
x-amz-meta-cache-control: max-age=86400
x-amz-version-id: wc5NaWeqDJ0yTvRZw3nPs_hfaBxiClqj
Cache-Control: max-age=86400
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: image/jpeg
Content-Length: 12800
x-amz-id-2: Ao3EOThe8TZACv3uJb0fwe7I2Iei7ReUvwzl797qiY7q+w0j4ku9buj82ojSfF6ld5wAz8xod3Y=
x-amz-meta-s3b-last-modified: 20170925T195726Z

GET
H/1.1 200
OK summer-heal-cover_high.jpg
onclive.s3.amazonaws.com/_media/_upload_image/ 13 KB
14 KB 121ms
120ms Image
image/jpeg 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_upload_image/summer-heal-cover_high.jpg
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: 9fa1eb2064bf50daa582bc9294206470785b876e372e81df9d32e9bb61688d2a

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:19 GMT
Last-Modified: Tue, 26 Sep 2017 14:40:44 GMT
Server: AmazonS3
x-amz-request-id: 402806C31AE6B8AC
ETag: "864e84b9ed63695850596ea76ca1571a"
x-amz-meta-cache-control: max-age=86400
x-amz-version-id: 1zCbLccXOP9MCPeCm3gc7aQwSAILe3g3
Cache-Control: max-age=86400
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: image/jpeg
Content-Length: 13292
x-amz-id-2: RaDhjFO5KVh/T35a3YFHwKh9i4YQW8Pj8Ir5VZsaWGOCuNeLtql4Rql7xSLGBCm0wWUSeEl+cO0=
x-amz-meta-s3b-last-modified: 20170925T195911Z

GET
H/1.1 200
OK healer-vol-11_high.jpg
onclive.s3.amazonaws.com/_media/_upload_image/ 13 KB
14 KB 150ms
149ms Image
image/jpeg 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_upload_image/healer-vol-11_high.jpg
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: 34a540a3c78ab10d1e22ca9c51f7d3942b6fd2010c84acec80ae53c7156d15ec

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:19 GMT
Last-Modified: Tue, 26 Sep 2017 14:39:07 GMT
Server: AmazonS3
x-amz-request-id: 010FD1DCBBA08C31
ETag: "16e3ba392afa58bcb346325f94a3bc6b"
x-amz-meta-cache-control: max-age=86400
x-amz-version-id: c.8DFVRgfVhEou7NbJ1WXOanUvlOGoOJ
Cache-Control: max-age=86400
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: image/jpeg
Content-Length: 13575
x-amz-id-2: tFuXOmmLpNnfJAvRStaPcm2j3eQPsuTTWDcOBWXPone3UYFB8sOofQ/VKFJVrvFrs3R11qJd/y0=
x-amz-meta-s3b-last-modified: 20170925T195836Z

GET
H/1.1 200
OK pubSliderBB.png
onclive.s3.amazonaws.com/_media/_core/ 6 KB
7 KB 131ms
131ms Image
binary/octet-stream 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_core/pubSliderBB.png
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: e2257c63993a7da111991635fc45fa6625c3410a26d16c04db16507406eb51f1

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:19 GMT
Last-Modified: Tue, 26 Sep 2017 13:49:49 GMT
Server: AmazonS3
x-amz-request-id: 8CD1C6489AA36DE7
ETag: "4cde8c9c2919412fab29713f09c3bd5d"
x-amz-meta-cache-control: max-age=86400
x-amz-version-id: 6Oio4mttggi4A3LhykFD_jttxIKJbp8R
Cache-Control: max-age=86400
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: binary/octet-stream
Content-Length: 6547
x-amz-id-2: 2+l6gTPpFMEXJyGqR/Fe9hBaVPXxef2yPfoqabQlD2mfWBzmLlzNI0Zs+gz7BGH0kMlzaBKjbiw=
Expires: Thu, 20 Jul 2017 02:09:09 GMT

GET
H/1.1 200
OK facebook_icon_s.png
onclive.s3.amazonaws.com/_media/_image/ 1 KB
2 KB 124ms
123ms Image
binary/octet-stream 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_image/facebook_icon_s.png
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: beebc08ec3432276eba8feeeca31a425c32efc1b10c3a05bbee3a85ec99eca6d

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:19 GMT
Last-Modified: Tue, 26 Sep 2017 13:54:35 GMT
Server: AmazonS3
x-amz-request-id: ED310A797260D024
ETag: "321388ab642010f029c8f05214a4bbc4"
x-amz-meta-cache-control: max-age=86400
x-amz-version-id: OxzHk1mAuyJvtZlTpgfYipZXm0BST0TT
Cache-Control: max-age=86400
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: binary/octet-stream
Content-Length: 1176
x-amz-id-2: toX8hRMtdQekACxBVDtRKN4gBbsZ4qE8WqfKNnFVK9WCwE+9VCQHEEbrPTGQqRQe3nvLxiIpP0M=

GET
H/1.1 200
OK twitter_icon_s.png
onclive.s3.amazonaws.com/_media/_image/ 1 KB
2 KB 124ms
124ms Image
binary/octet-stream 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_image/twitter_icon_s.png
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: 2b9c86c93bee929d1b6165572bba8b534decf4535ff0b09442b508fb5910a2de

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:19 GMT
Last-Modified: Tue, 26 Sep 2017 13:54:45 GMT
Server: AmazonS3
x-amz-request-id: 86002036F7759010
ETag: "a734368172cf2057c71c8dba8b047c62"
x-amz-meta-cache-control: max-age=86400
x-amz-version-id: Uq_EzB8BErmvAy.GvCQ9_QKQ8Bst1cex
Cache-Control: max-age=86400
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: binary/octet-stream
Content-Length: 1198
x-amz-id-2: JembnCkQ56oHMihHaLLE6Scnq+omzhxH3e6/JybD4si0nQ3LRb9WJnfcQXAB3kTbQbSitXoW+y8=

GET
H/1.1 200
OK appleapp_icon_s.png
onclive.s3.amazonaws.com/_media/_image/ 908 B
1 KB 119ms
119ms Image
binary/octet-stream 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_image/appleapp_icon_s.png
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: ceb1de7e0a0d7b7025a2e363fc1136bcf4ebf79786feb7f4e5ec1f748e71bd71

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:19 GMT
Last-Modified: Tue, 26 Sep 2017 13:54:34 GMT
Server: AmazonS3
x-amz-request-id: 6BC691720F3B8CA7
ETag: "074bdad20143e266c670b1c6cb421d9c"
x-amz-meta-cache-control: max-age=86400
x-amz-version-id: 1UpqginvsiQj8SiglJf2fqBvHF4APnfI
Cache-Control: max-age=86400
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: binary/octet-stream
Content-Length: 908
x-amz-id-2: B+0iON47II86rAb1Ar4vDAF3TxQLNyYuafcd2sNlArfqK4LVhvM7bgNPTjYmZQiSxMzyhK0suRg=

GET
H/1.1 200
OK youtube_icon_s.png
onclive.s3.amazonaws.com/_media/_image/ 4 KB
4 KB 134ms
133ms Image
binary/octet-stream 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_image/youtube_icon_s.png
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: 052c477d29f6341e28c511d1d227af2b1738a28ccbf26d4e9ee6900d8ac99058

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:19 GMT
Last-Modified: Tue, 26 Sep 2017 13:54:45 GMT
Server: AmazonS3
x-amz-request-id: 8C478B61B300AC13
ETag: "0bebbada29fbd9bebb7ec9200855bd3b"
x-amz-meta-cache-control: max-age=86400
x-amz-version-id: 1cH_apP43FxI7M6utsBkekQTOM8Ss3Pp
Cache-Control: max-age=86400
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: binary/octet-stream
Content-Length: 3918
x-amz-id-2: 817nI63IAXirlTI1AHNlAvexOAd7ymKhb8VlQ5O9lXBymGXn2l65XMFFrWwuLFDX2nOrHct1I2w=

GET
H/1.1 200
OK linkedin-button.png
onclive.s3.amazonaws.com/_media/_image/ 4 KB
4 KB 128ms
128ms Image
binary/octet-stream 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_image/linkedin-button.png
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: 530752a1a909afe7dbc915281854ac7d8e745444c7b15961a72dfc0000931864

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:19 GMT
Last-Modified: Tue, 26 Sep 2017 13:54:37 GMT
Server: AmazonS3
x-amz-request-id: 07E01CC227E4A166
ETag: "14d9f91d7f04d2bde0f2e332f6bbc10c"
x-amz-meta-cache-control: max-age=86400
x-amz-version-id: JzMdhkf4GcDixI9b_zbBNluxYcsRIov6
Cache-Control: max-age=86400
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: binary/octet-stream
Content-Length: 3760
x-amz-id-2: Ix3G8rmx6p/WEs1iNCFy9lskxcR6wzz7acpCyvXXPVd5ucmGcvoMxFakYmxVuZTPlzSsriRWfOs=

GET
H/1.1 200
OK /
onclive.s3.amazonaws.com/_media/_upload_image/ 1 B
525 B 123ms
123ms Image
binary/octet-stream 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_upload_image/
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:19 GMT
Last-Modified: Tue, 26 Sep 2017 14:21:49 GMT
Server: AmazonS3
x-amz-request-id: E3B300058129D749
ETag: "cfcd208495d565ef66e7dff9f98764da"
x-amz-meta-cache-control: max-age=86400
x-amz-version-id: uxIL7j2umAj1qlEZAWnAxERHw0bU1p7w
Cache-Control: max-age=86400
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: binary/octet-stream
Content-Length: 1
x-amz-id-2: L82n4wiBorqUOo2+i8nuEVYQmjDncI86gYOMGpQMNNgo1gl6q0eaP5ge4Z81MzZLqrVa6dIn1ok=

GET
H2 200 gpt.js Show response
www.googletagservices.com/tag/js/ 46 KB
15 KB 41ms
40ms Script
text/javascript 2a00:1450:4001:815::2002
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagservices.com/tag/js/gpt.js

Requested by

Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:815::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

sffe /

Resource Hash

07242e8854853219c437a8b0cc7ce768a6e4a85693ff9de1e6910e764c643642

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:15 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: sffe
etag: "310 / 761 of 1000 / last-modified: 1571336459"
vary: Accept-Encoding
content-type: text/javascript
status: 200
cache-control: private, max-age=900, stale-while-revalidate=3600
timing-allow-origin: *
alt-svc: quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 14753
x-xss-protection: 0
expires: Fri, 18 Oct 2019 15:03:15 GMT

GET
H2 200 analytics.js Show response
www.google-analytics.com/ 43 KB
17 KB 6ms
6ms Script
text/javascript 2a00:1450:4001:815::200e
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google-analytics.com/analytics.js

Requested by

Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:815::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

Golfe2 /

Resource Hash

dbb67c620eaabf6679a314db18d3ae43037aef71ab27422e6feec08ee987cc0a

Security Headers

Name	Value
Strict-Transport-Security	max-age=10886400; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security: max-age=10886400; includeSubDomains; preload
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Mon, 19 Aug 2019 17:22:41 GMT
server: Golfe2
age: 4145
date: Fri, 18 Oct 2019 13:54:10 GMT
vary: Accept-Encoding
content-type: text/javascript
status: 200
cache-control: public, max-age=7200
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 17803
expires: Fri, 18 Oct 2019 15:54:10 GMT

GET
H2 200 hotjar-722008.js Show response
static.hotjar.com/c/ 8 KB
4 KB 62ms
24ms Script
application/javascript 147.75.33.59
Packet Host

General

Check archive.org

Show headers Download Go to

Full URL

https://static.hotjar.com/c/hotjar-722008.js?sv=5

Requested by

Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W2MSXQC

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

147.75.33.59 Amsterdam, Netherlands, ASN54825 (PACKET - Packet Host, Inc., US),

Reverse DNS

pkt-ams-k1-4

Software

openresty /

Resource Hash

6fbe64ea7725f5e74f95a6bfcbb4aac8a77a777f72878cab6f2e4cffa79b8eab

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:15 GMT
content-encoding: gzip
x-content-type-options: nosniff
section-io-tag: hotjar
age: 19
status: 200
section-io-cache: Hit
vary: Accept-Encoding
content-length: 3227
server: openresty
cache-control: max-age=60
x-frame-options: SAMEORIGIN
etag: W/f7a318ed9e79fa65476d6beba71c3914
access-control-max-age: 600
section-io-origin-status: 304
access-control-allow-origin: *
x-cache-hit: 1
section-io-origin-time-seconds: 0.068
section-io-id: 2793142941255af2d3b731531f216201
accept-ranges: bytes
content-type: application/javascript

GET
H2 200 conversion_async.js Show response
www.googleadservices.com/pagead/ 24 KB
9 KB 37ms
36ms Script
text/javascript 172.217.21.194
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googleadservices.com/pagead/conversion_async.js

Requested by

Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W2MSXQC

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

172.217.21.194 , United States, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

fra16s12-in-f2.1e100.net

Software

cafe /

Resource Hash

04cc99186aa1ed2c9e0989ad7f6a2e180508c8656caef8cd2b153fa8dbba9038

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:15 GMT
content-encoding: gzip
x-content-type-options: nosniff
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status: 200
content-disposition: attachment; filename="f.txt"
alt-svc: quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 9198
x-xss-protection: 0
server: cafe
etag: 4566352449703540938
vary: Accept-Encoding
content-type: text/javascript; charset=UTF-8
cache-control: private, max-age=3600
timing-allow-origin: *
expires: Fri, 18 Oct 2019 15:03:15 GMT

GET
H2 200 / Show response
2bc72976f5be45bfaa237bd9b8fd5ddb.js.ubembed.com/ 486 B
657 B 337ms
28ms Script
application/json 151.101.13.131
Fastly

General

Check archive.org

Show headers Download Go to

Full URL: https://2bc72976f5be45bfaa237bd9b8fd5ddb.js.ubembed.com/
Requested by: Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W2MSXQC
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 151.101.13.131 Frankfurt am Main, Germany, ASN54113 (FASTLY - Fastly, US),
Reverse DNS
Software: /
Resource Hash: faa0d46bfd0ead7551709e895e60976f6f6c030383630cf404f08511472b13ef

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:15 GMT
content-encoding: br
x-backend-region: eu_west_1
age: 2680
x-amz-apigw-id: Bwx1PFtjjoEFr-Q=
etag: eaf2647708c729d5ba054d84a4fb382a-v0.177.0
vary: Accept-Encoding
x-cache: Miss from cloudfront, HIT
content-type: application/json
status: 200
cache-control: max-age=0, must-revalidate
x-amz-cf-pop: FRA6-C1
accept-ranges: none
access-control-allow-origin: *

GET
H2 200 integrator.js Show response
adservice.google.de/adsid/ 109 B
656 B 30ms
18ms Script
application/javascript 2a00:1450:4001:815::2002
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://adservice.google.de/adsid/integrator.js?domain=www.onclive.com

Requested by

Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:815::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

cafe /

Resource Hash

0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin: *
date: Fri, 18 Oct 2019 15:03:15 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: cafe
p3p: CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status: 200
cache-control: private, no-cache, no-store
content-disposition: attachment; filename="f.txt"
content-type: application/javascript; charset=UTF-8
alt-svc: quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 104
x-xss-protection: 0

GET
H2 200 integrator.js Show response
adservice.google.com/adsid/ 109 B
656 B 29ms
16ms Script
application/javascript 2a00:1450:4001:815::2002
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://adservice.google.com/adsid/integrator.js?domain=www.onclive.com

Requested by

Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:815::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

cafe /

Resource Hash

0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin: *
date: Fri, 18 Oct 2019 15:03:15 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: cafe
p3p: CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status: 200
cache-control: private, no-cache, no-store
content-disposition: attachment; filename="f.txt"
content-type: application/javascript; charset=UTF-8
alt-svc: quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 104
x-xss-protection: 0

GET
H2 200 pubads_impl_2019101401.js Show response
securepubads.g.doubleclick.net/gpt/ 156 KB
58 KB 116ms
60ms Script
text/javascript 172.217.23.98
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js

Requested by

Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

172.217.23.98 , United States, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

fra16s45-in-f2.1e100.net

Software

sffe /

Resource Hash

f8800772f0dd827877029d9d634a170a156ff82b6b6bdf251b62c750b73cfe93

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:15 GMT
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Mon, 14 Oct 2019 13:08:16 GMT
server: sffe
vary: Accept-Encoding
content-type: text/javascript
status: 200
cache-control: private, immutable, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 58589
x-xss-protection: 0
expires: Fri, 18 Oct 2019 15:03:15 GMT

GET
H2

200

ga-audiences
www.google.de/ads/
Redirect Chain

https://www.google-analytics.com/r/collect?v=1&_v=j79&a=1327822741&t=pageview&_s=1&dl=https%3A%2F%2Fwww.onclive.com%2Fweb-exclusives%2Ffda-grants-trastuzumab-deruxtecan-priority-review-for-her2-bre...
https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-11140057-22&cid=588703558.1571410995&jid=125417665&_gid=646766858.1571410995&gjid=275879088&_v=j79&z=825255005
https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-11140057-22&cid=588703558.1571410995&jid=125417665&_v=j79&z=825255005
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-11140057-22&cid=588703558.1571410995&jid=125417665&_v=j79&z=825255005&slf_rd=1&random=1898419658

42 B
109 B

28ms
28ms

Image
image/gif

2a00:1450:4001:819::2003
Google LLC

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-11140057-22&cid=588703558.1571410995&jid=125417665&_v=j79&z=825255005&slf_rd=1&random=1898419658

Requested by

Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:819::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

cafe /

Resource Hash

ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Fri, 18 Oct 2019 15:03:15 GMT
x-content-type-options: nosniff
server: cafe
timing-allow-origin: *
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status: 200
cache-control: no-cache, no-store, must-revalidate
content-type: image/gif
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 42
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma: no-cache
date: Fri, 18 Oct 2019 15:03:15 GMT
x-content-type-options: nosniff
server: cafe
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status: 302
content-type: text/html; charset=UTF-8
location: https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-11140057-22&cid=588703558.1571410995&jid=125417665&_v=j79&z=825255005&slf_rd=1&random=1898419658
cache-control: no-cache, no-store, must-revalidate
timing-allow-origin: *
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 0
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H/1.1 200
OK jquery.blockUI.min.js Show response
d14575uifa02kd.cloudfront.net/js/ 9 KB
4 KB 1351ms
26ms Script
application/x-javascript 143.204.98.216
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://d14575uifa02kd.cloudfront.net/js/jquery.blockUI.min.js
Requested by: Host: lucid.mjhassoc.com
URL: https://lucid.mjhassoc.com/lucid.min.js?v=1.123
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 143.204.98.216 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: server-143-204-98-216.fra50.r.cloudfront.net
Software: AmazonS3 /
Resource Hash: 71886bc1bfc23ced5fcd32fbca851271d280c959fdbf45df49841d171d0d056a

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id: null
Content-Encoding: gzip
Last-Modified: Thu, 24 Sep 2015 15:43:34 GMT
Server: AmazonS3
Age: 27947
Date: Fri, 18 Oct 2019 07:17:30 GMT
Vary: Accept-Encoding
X-Cache: Hit from cloudfront
Content-Type: application/x-javascript
Via: 1.1 a148356b14492df0e216c234ac2c2308.cloudfront.net (CloudFront)
Connection: keep-alive
Transfer-Encoding: chunked
X-Amz-Cf-Pop: FRA50-C1
X-Amz-Cf-Id: fXpmkf7ppCGAWl37dz5cpafkSvuw73iXAvsleKCNy3Sn8sANFAdcZA==

GET
H2 200 iframe_api Show response
www.youtube.com/ 859 B
923 B 20ms
20ms Script
application/javascript 2a00:1450:4001:815::200e
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://www.youtube.com/iframe_api

Requested by

Host: lucid.mjhassoc.com
URL: https://lucid.mjhassoc.com/beam.min.js?v=1.123

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:815::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

YouTube Frontend Proxy /

Resource Hash

16dd54686a3ed4ca169cba44af157ea072d91930a6b5ad3690b4651820e5e0b2

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:15 GMT
x-content-type-options: nosniff
server: YouTube Frontend Proxy
content-type: application/javascript
status: 200
cache-control: no-cache
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 859
x-xss-protection: 0
expires: Tue, 27 Apr 1971 19:44:06 EST

GET
H/1.1 200
OK nav30_bg_full.png
onclive.s3.amazonaws.com/_media/_core/ 33 KB
33 KB 1372ms
159ms Image
binary/octet-stream 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_core/nav30_bg_full.png
Requested by: Host: ajax.googleapis.com
URL: https://ajax.googleapis.com/ajax/libs/jquery/2.1.4/jquery.min.js
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: e8a79c6e4212194330e30025416175ff4f2362aba2bfce9cf4e698d3154c04be

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/_css/css.css?v=9.59
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:17 GMT
Last-Modified: Tue, 26 Sep 2017 13:49:48 GMT
Server: AmazonS3
x-amz-request-id: 1EC6891F841FAD5A
ETag: "872b68a46a88fcff43b0639656b30d0b"
x-amz-meta-cache-control: max-age=86400
x-amz-version-id: lLutD95B9lXcidrPHT_aSPR4mhYYUCyq
Cache-Control: max-age=86400
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: binary/octet-stream
Content-Length: 33697
x-amz-id-2: wlJKf7Fc02Eqzr7nfqPHeANLYFnhyPL8sAdM6ODflH9IL6OD/nHtuazcZCJwOudl0B8yLRWH+Gc=
Expires: Thu, 20 Jul 2017 02:09:09 GMT

GET
H/1.1 200
OK nav31_bg_main.png
onclive.s3.amazonaws.com/_media/_core/ 46 KB
47 KB 1369ms
155ms Image
image/png 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_core/nav31_bg_main.png
Requested by: Host: ajax.googleapis.com
URL: https://ajax.googleapis.com/ajax/libs/jquery/2.1.4/jquery.min.js
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: 9dfd72b76f7fdd577eb263965292073f51baba7495d857a22abc71ed267c566d

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/_css/css.css?v=9.59
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:17 GMT
Last-Modified: Tue, 26 Sep 2017 13:49:48 GMT
Server: AmazonS3
x-amz-request-id: 6B324BE14D4B8C2D
ETag: "ece7f479e09f1aab48ec7821fc48ed52"
x-amz-meta-cache-control: max-age=86400
x-amz-version-id: AmE8s5QpJFx.TJBnAYAu4_9HwKl5Y1r2
Cache-Control: max-age=86400
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: image/png
Content-Length: 47568
x-amz-id-2: /knq3tfAYshuUbOp0DNocJyv4vVwZiNZHc3Uby6RibwPeki47pnwAmNaZfON4ESANIr9600HJ5E=
x-amz-meta-s3b-last-modified: 20161101T154023Z

GET
H/1.1 200
OK empty.gif
onclive.s3.amazonaws.com/_media/_core/ 630 B
1 KB 1584ms
117ms Image
image/gif 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_core/empty.gif
Requested by: Host: ajax.googleapis.com
URL: https://ajax.googleapis.com/ajax/libs/jquery/2.1.4/jquery.min.js
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: 3ebd084402900155af9f8c0911dd768af8a2b66ad30a1e65658b43be05d86cc4

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/_css/css.css?v=9.59
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:17 GMT
Last-Modified: Tue, 26 Sep 2017 13:49:46 GMT
Server: AmazonS3
x-amz-request-id: 72ECE0ADF638274C
ETag: "66fc669fa7ebca750e905bd9314bc515"
x-amz-meta-cache-control: max-age=86400
x-amz-version-id: L7UKeJqeLXIZVFi5Prn4cvvzH0eOD22R
Cache-Control: max-age=86400
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: image/gif
Content-Length: 630
x-amz-id-2: wgdlKkxo6WkaA+kO+aLCxDYfmERvaU8kznPydpkHBgu1gqUXuce9jqIH/VJjl3YhnDyVQ1BqCKw=
x-amz-meta-s3b-last-modified: 20161101T160402Z

GET
H/1.1 200
OK CLR131_v2.jpg
onclive.s3.amazonaws.com/_media/_image/ 371 KB
371 KB 1332ms
117ms Image
image/jpeg 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_image/CLR131_v2.jpg
Requested by: Host: ajax.googleapis.com
URL: https://ajax.googleapis.com/ajax/libs/jquery/2.1.4/jquery.min.js
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: fabc02d15710bb91c4d74a7cbfd24c2bdc8262785492b3f0a2bdd7ac7c982cb8

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/_css/css.css?v=9.59
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:17 GMT
Last-Modified: Mon, 14 Oct 2019 13:29:09 GMT
Server: AmazonS3
x-amz-request-id: F4FE95E312B38461
ETag: "42de1b23f9bf2397141c5dc31e3ff3cb"
x-amz-version-id: fRZgOPHeAIgpD_CA8rchI8Z58xZzexCS
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: image/jpeg
Content-Length: 379418
x-amz-id-2: 8epOVWBw/dJh12qFSHzYBVw6F3Qd1wSyGn5oMi0xqqmTjx4K1vKY+pqe932tfyK9vEJb9gBI9I0=

GET
H/1.1 200
OK section_title_bg.png
onclive.s3.amazonaws.com/_media/_core/ 3 KB
3 KB 1669ms
124ms Image
binary/octet-stream 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_core/section_title_bg.png
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: c80846944907ed9e8616f71172949f8e3c70877e1e2e8ef3880c8170246daee1

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/_css/css.css?v=9.59
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:17 GMT
Last-Modified: Tue, 26 Sep 2017 13:49:50 GMT
Server: AmazonS3
x-amz-meta-s3cmd-attrs: uid:33/gname:satellite/uname:www-data/gid:1003/mode:33272/mtime:1397062842/atime:1418841958/ctime:1405619926
x-amz-request-id: 679A61BEEA2D2086
ETag: "d1059a20bf8f3382b793d7234d7425ac"
x-amz-meta-cache-control: max-age=86400
x-amz-version-id: BlqHlLj6aT9D9lEBNaq9Qwl.R5yLSgvJ
Cache-Control: max-age=86400
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: binary/octet-stream
Content-Length: 2826
x-amz-id-2: DqRxz46ydn2V+51KpQqva8dOv3FL1izyEgo9urC0e12gFW2OOVG10TJlm6Md/Ll3sZCIapa6aVk=
Expires: Thu, 20 Jul 2017 02:09:09 GMT

GET
H2 200 modules.c8b73d293ba6e2f7c665.js Show response
script.hotjar.com/ 431 KB
73 KB 1074ms
18ms Script
application/javascript 147.75.84.33
Packet Host

General

Check archive.org

Show headers Download Go to

Full URL: https://script.hotjar.com/modules.c8b73d293ba6e2f7c665.js
Requested by: Host: static.hotjar.com
URL: https://static.hotjar.com/c/hotjar-722008.js?sv=5
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 147.75.84.33 Parsippany, United States, ASN54825 (PACKET - Packet Host, Inc., US),
Reverse DNS
Software: /
Resource Hash: eb4747d9593a2ff2ae1cd49338bb1d5121c21df7e9bd7e11471ef8dc43dbd1c6

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:16 GMT
content-encoding: br
last-modified: Thu, 17 Oct 2019 12:05:37 GMT
status: 200
etag: "fd94f49e11a30d7540e1ae15f19b929e"
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: *
cache-control: max-age=31536000
section-io-origin-time-seconds: 0.053
section-io-origin-status: 200
accept-ranges: bytes
section-io-id: c875809a0e2304d3af8f1999fb66f442
content-length: 74002

GET
H2 200 async-buttons.js Show response
ws.sharethis.com/button/ 89 KB
19 KB 8ms
8ms Script
application/javascript 2600:9000:21f3:6200:3:c04e:c780:93a1
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://ws.sharethis.com/button/async-buttons.js
Requested by: Host: ws.sharethis.com
URL: https://ws.sharethis.com/button/buttons.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 2600:9000:21f3:6200:3:c04e:c780:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software: nginx/1.12.2 /
Resource Hash: 764262648df23049f6c23fe89dc20106a96c4624412a8ad20ec54bb7bbae6c6e

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Wed, 16 Oct 2019 03:07:23 GMT
content-encoding: gzip
server: nginx/1.12.2
age: 215751
etag: W/"5d9e5d6c-162e8"
vary: Accept-Encoding
x-cache: Hit from cloudfront
content-type: application/javascript
status: 200
cache-control: max-age=259200
x-amz-cf-pop: FRA2-C2
x-robots-tag: noindex, nofollow
x-amz-cf-id: fmsYHYEN3N5JL2DZMTe8njMLXi7pR4eUWtw8sJSNonB29oGyZtorKw==
via: 1.1 56fad5a50ef67bd961b9722ed0931839.cloudfront.net (CloudFront)
expires: Sat, 19 Oct 2019 03:07:23 GMT

GET
H2 200 uwt.js Show response
static.ads-twitter.com/ 5 KB
2 KB 1093ms
25ms Script
application/javascript 151.101.112.157
Fastly

General

Check archive.org

Show headers Download Go to

Full URL: https://static.ads-twitter.com/uwt.js
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 151.101.112.157 Frankfurt am Main, Germany, ASN54113 (FASTLY - Fastly, US),
Reverse DNS
Software: /
Resource Hash: 319949c8c08b86e9c35ea542c0dc0c30cedaa9b8d3d3c3327a36c91aefbd8af5

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:16 GMT
content-encoding: gzip
age: 24624
x-cache: HIT
p3p: CP="CAO DSP LAW CURa ADMa DEVa TAIa PSAa PSDa IVAa IVDa OUR BUS IND UNI COM NAV INT"
status: 200
content-length: 1954
x-served-by: cache-hhn4052-HHN
last-modified: Tue, 23 Jan 2018 20:09:00 GMT
x-timer: S1571410996.400537,VS0,VE0
etag: "b7b33882a4f3ffd5cbf07434f3137166+gzip"
vary: Accept-Encoding,Host
content-type: application/javascript; charset=utf-8
via: 1.1 varnish
cache-control: no-cache
accept-ranges: bytes

GET
H2 200 fa-regular-400.woff2
use.fontawesome.com/releases/v5.1.0/webfonts/ 15 KB
15 KB 22ms
22ms Font
font/woff2 23.111.9.35
Highwinds Network...

General

Check archive.org

Show headers Download Go to

Full URL: https://use.fontawesome.com/releases/v5.1.0/webfonts/fa-regular-400.woff2
Requested by: Host: ajax.googleapis.com
URL: https://ajax.googleapis.com/ajax/libs/jquery/2.1.4/jquery.min.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 23.111.9.35 Phoenix, United States, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
Software: NetDNA-cache/2.2 /
Resource Hash: 1669bec36f12c35a00a2d23cf71b6061c85b8435f5c26445aab338f88dfe6629

Request headers

Sec-Fetch-Mode: cors
Referer: https://use.fontawesome.com/releases/v5.1.0/css/all.css
Origin: https://www.onclive.com
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:15 GMT
last-modified: Wed, 20 Jun 2018 20:19:32 GMT
server: NetDNA-cache/2.2
status: 200
etag: "a3715c6fe264a51f1d9260b447ff46bc"
vary: Origin, Access-Control-Request-Headers, Access-Control-Request-Method, Accept-Encoding
access-control-allow-methods: GET
content-type: font/woff2
access-control-allow-origin: *
access-control-max-age: 3000
cache-control: max-age=31556926
x-cache: HIT
accept-ranges: bytes
content-length: 14952

GET
H2 200 bx_loader.gif
www.onclive.com/_js/bxslider/ 8 KB
9 KB 102ms
102ms Image
image/gif 52.206.141.94
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.onclive.com/_js/bxslider/bx_loader.gif

Requested by

Host: ajax.googleapis.com
URL: https://ajax.googleapis.com/ajax/libs/jquery/2.1.4/jquery.min.js

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

52.206.141.94 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),

Reverse DNS

ec2-52-206-141-94.compute-1.amazonaws.com

Software

Apache/2.4.7 (Ubuntu) /

Resource Hash

6d46e2cf165a5a0584afba7bc9663da292ee08c97cfc7613de6013ed05be892a

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/_js/bxslider/jquery.bxslider.css
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:15 GMT
last-modified: Tue, 15 Oct 2019 20:56:04 GMT
server: Apache/2.4.7 (Ubuntu)
etag: "2185-594f9366a6ea3"
content-type: image/gif
status: 200
content-security-policy: upgrade-insecure-requests
accept-ranges: bytes
content-length: 8581

GET
H/1.1 200
OK confSliderRight.png
onclive.s3.amazonaws.com/_media/_core/ 542 B
1 KB 1759ms
129ms Image
binary/octet-stream 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_core/confSliderRight.png
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: 68ec2f02b2f326dcce73652d2fa85c30bfbafbca0de4be247bfb7b456ee79029

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:18 GMT
Last-Modified: Tue, 26 Sep 2017 13:49:46 GMT
Server: AmazonS3
x-amz-request-id: 871935C38083097E
ETag: "5469a4e7e70e8d9666c62310f5962dde"
x-amz-meta-cache-control: max-age=86400
x-amz-version-id: Bct3RGPDzbxF0X1HlPWxaOTy3Qoc4LSc
Cache-Control: max-age=86400
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: binary/octet-stream
Content-Length: 542
x-amz-id-2: B/OlvmLRGMtTnad5XoesqqpXDxhwu5nkDs8sPMCnv+dgPhKulouX88QfoQOfdTaXO+qI06cjLqI=
Expires: Thu, 20 Jul 2017 02:09:09 GMT

GET
H/1.1 200
OK confSliderLeft.png
onclive.s3.amazonaws.com/_media/_core/ 539 B
1 KB 1658ms
120ms Image
binary/octet-stream 52.216.184.59
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://onclive.s3.amazonaws.com/_media/_core/confSliderLeft.png
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.184.59 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1-w.amazonaws.com
Software: AmazonS3 /
Resource Hash: 8bbffd9817315dc68780a9cf77a2c196b9209cc9a75eeaec403af409fd02610b

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:17 GMT
Last-Modified: Tue, 26 Sep 2017 13:49:46 GMT
Server: AmazonS3
x-amz-request-id: A54F80FC61E56C11
ETag: "8532227f1153bdde2369ecc9f92a69f1"
x-amz-meta-cache-control: max-age=86400
x-amz-version-id: jlnJjEsHF6aNyih23gudk_GVlUZPOcZe
Cache-Control: max-age=86400
x-amz-replication-status: COMPLETED
Accept-Ranges: bytes
Content-Type: binary/octet-stream
Content-Length: 539
x-amz-id-2: dTCmWw4QV8SmiEtH73r7M074iKHQgvtfNCtO6n95+pfLtOPN4puDB9JFgO9L3KpZ8+j5JWaNQmE=
Expires: Thu, 20 Jul 2017 02:09:09 GMT

GET
H/1.1 200
OK to98r5blo.js Show response
cdn.krxd.net/controltag/ 9 KB
4 KB 90ms
30ms Script
text/javascript 151.101.12.175
Fastly

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.krxd.net/controltag/to98r5blo.js
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 151.101.12.175 Frankfurt am Main, Germany, ASN54113 (FASTLY - Fastly, US),
Reverse DNS
Software: /
Resource Hash: f5771d76abc39293979f14ac279932674dd70fc8b53732ee295d6e792fa5dcdd

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

X-CDN-Backend: 4FrRTvEr9h480D4BywjehZ--F_config_service_ash_prod
Date: Fri, 18 Oct 2019 15:03:15 GMT
Via: 1.1 varnish, 1.1 varnish
Age: 619
X-Cache: MISS, HIT, HIT
X-App-Cache: HIT
Connection: keep-alive
Content-Encoding: gzip
Content-Length: 3010
X-Served-By: config-service-a004-ash-prod.krxd.net, cache-iad2145-IAD, cache-fra19139-FRA
X-Response-Time: 0
X-Do-Esi: esi
X-Timer: S1571410995.417927,VS0,VE0
ETag: "b6ee5b206cef46f278c75694ac9168e3757e8992"
Vary: Accept-Encoding
Content-Type: text/javascript; charset=utf-8
Cache-Control: public, max-age=1200
Accept-Ranges: bytes
X-Age: 0
X-Cache-Hits: 0, 1, 1

GET
H2 200 portal.html
c.sharethis.mgr.consensu.org/ Frame 8103 0
0 22ms
7ms Document
text/html 2600:9000:2156:8600:c:a9b7:ddc0:93a1
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://c.sharethis.mgr.consensu.org/portal.html
Requested by: Host: ws.sharethis.com
URL: https://ws.sharethis.com/button/buttons.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 2600:9000:2156:8600:c:a9b7:ddc0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software: /
Resource Hash

Request headers

:method: GET
:authority: c.sharethis.mgr.consensu.org
:scheme: https
:path: /portal.html
pragma: no-cache
cache-control: no-cache
upgrade-insecure-requests: 1
user-agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode: nested-navigate
accept: text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site: cross-site
referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
accept-encoding: gzip, deflate, br
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode: nested-navigate
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Response headers

status: 200
content-type: text/html; charset=utf-8
accept-ranges: bytes
content-encoding: gzip
edge-control: cache-maxage=60m,downstream-ttl=60m
last-modified: Mon, 30 Sep 2019 19:20:14 GMT
date: Fri, 18 Oct 2019 14:57:12 GMT
cache-control: max-age=600, public
etag: W/"361b-16d839db5b0"
vary: Accept-Encoding
x-cache: Hit from cloudfront
via: 1.1 d627b75d0c1aedd3691390ac8498d3b0.cloudfront.net (CloudFront)
x-amz-cf-pop: FRA50-C1
x-amz-cf-id: m6z0n0NSaenWH7nvQ4jbdRL96OsRo_jQSrAeMRP6_FkdwZBY9WlpJA==
age: 364

GET
H2 200 buttons-secure.css
ws.sharethis.com/button/css/ 23 KB
4 KB 7ms
7ms Stylesheet
text/css 2600:9000:21f3:6200:3:c04e:c780:93a1
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://ws.sharethis.com/button/css/buttons-secure.css
Requested by: Host: ws.sharethis.com
URL: https://ws.sharethis.com/button/async-buttons.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 2600:9000:21f3:6200:3:c04e:c780:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software: nginx/1.12.2 /
Resource Hash: 95dc1b83a7c030dd13ab3e29df921f10e04208b28734f172ea232854264c3b05

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Thu, 17 Oct 2019 16:43:14 GMT
content-encoding: gzip
last-modified: Wed, 09 Oct 2019 22:29:37 GMT
server: nginx/1.12.2
age: 80401
etag: W/"5d9e5f51-5a76"
vary: Accept-Encoding
x-cache: Hit from cloudfront
content-type: text/css
status: 200
x-amz-cf-pop: FRA2-C2
x-robots-tag: noindex, nofollow
content-length: 3851
via: 1.1 56fad5a50ef67bd961b9722ed0931839.cloudfront.net (CloudFront)
x-amz-cf-id: LpBiawJ-JC5Vq6ZxxAac6qj9hMOCIo-edljMDlU7oWQbrG-V8NV-fQ==

GET
H2 200 email_32.png
ws.sharethis.com/images/2017/ 1 KB
2 KB 7ms
6ms Image
image/png 2600:9000:21f3:6200:3:c04e:c780:93a1
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://ws.sharethis.com/images/2017/email_32.png
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 2600:9000:21f3:6200:3:c04e:c780:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software: nginx/1.12.2 /
Resource Hash: c3a537ae5d8020c10896418cb8658af444cbb3f89d3543c7db596b624e38690d

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Thu, 19 Sep 2019 05:48:42 GMT
via: 1.1 56fad5a50ef67bd961b9722ed0931839.cloudfront.net (CloudFront)
server: nginx/1.12.2
age: 1571131
etag: "5d82ad27-566"
x-cache: Hit from cloudfront
content-type: image/png
status: 200
cache-control: max-age=31536000
x-amz-cf-pop: FRA2-C2
accept-ranges: bytes
x-robots-tag: noindex, nofollow
content-length: 1382
x-amz-cf-id: 7-T90_9a_oE6PlMmIJNDOZdppLW6K2GBg_4jFtq_Cpfehe0nyrVC_A==
expires: Fri, 18 Sep 2020 05:48:42 GMT

GET
H2 200 facebook_32.png
ws.sharethis.com/images/2017/ 1 KB
2 KB 9ms
8ms Image
image/png 2600:9000:21f3:6200:3:c04e:c780:93a1
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://ws.sharethis.com/images/2017/facebook_32.png
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 2600:9000:21f3:6200:3:c04e:c780:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software: nginx/1.12.2 /
Resource Hash: 732d3038cffc852adde57cc51509924b478a45c898cefbb6e46b04448feff7e5

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Wed, 18 Sep 2019 23:58:20 GMT
via: 1.1 56fad5a50ef67bd961b9722ed0931839.cloudfront.net (CloudFront)
server: nginx/1.12.2
age: 2559895
etag: "5d82ad27-497"
x-cache: Hit from cloudfront
content-type: image/png
status: 200
cache-control: max-age=31536000
x-amz-cf-pop: FRA2-C2
accept-ranges: bytes
x-robots-tag: noindex, nofollow
content-length: 1175
x-amz-cf-id: g2RQKCRoSp_SzW1gi0cX19HN-Q7r_su7yljGB9wSUJelBmR4jQtafQ==
expires: Thu, 17 Sep 2020 23:58:20 GMT

GET
H2 200 twitter_32.png
ws.sharethis.com/images/2017/ 1 KB
2 KB 10ms
9ms Image
image/png 2600:9000:21f3:6200:3:c04e:c780:93a1
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://ws.sharethis.com/images/2017/twitter_32.png
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 2600:9000:21f3:6200:3:c04e:c780:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software: nginx/1.12.2 /
Resource Hash: 39446b399dd1911651e5517b059c649de4a58c3d89ddafa594a6867a9b201564

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Wed, 18 Sep 2019 23:58:20 GMT
via: 1.1 56fad5a50ef67bd961b9722ed0931839.cloudfront.net (CloudFront)
server: nginx/1.12.2
age: 2559895
etag: "5d82ad27-53a"
x-cache: Hit from cloudfront
content-type: image/png
status: 200
cache-control: max-age=31536000
x-amz-cf-pop: FRA2-C2
accept-ranges: bytes
x-robots-tag: noindex, nofollow
content-length: 1338
x-amz-cf-id: GugBsrgOxZX8QSYyP_70KH96BYkATfgyGO451GooPasqQA0_6V2tWA==
expires: Thu, 17 Sep 2020 23:58:20 GMT

GET
H2 200 linkedin_32.png
ws.sharethis.com/images/2017/ 1 KB
2 KB 9ms
8ms Image
image/png 2600:9000:21f3:6200:3:c04e:c780:93a1
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://ws.sharethis.com/images/2017/linkedin_32.png
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 2600:9000:21f3:6200:3:c04e:c780:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software: nginx/1.12.2 /
Resource Hash: e083ca305fe5020595b52c04499258219f69c8cb83ec0ffc1eb0f22815f5c60f

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Thu, 19 Sep 2019 02:00:21 GMT
via: 1.1 56fad5a50ef67bd961b9722ed0931839.cloudfront.net (CloudFront)
server: nginx/1.12.2
age: 1618353
etag: "5d82ad27-4c9"
x-cache: Hit from cloudfront
content-type: image/png
status: 200
cache-control: max-age=31536000
x-amz-cf-pop: FRA2-C2
accept-ranges: bytes
x-robots-tag: noindex, nofollow
content-length: 1225
x-amz-cf-id: 6cmqYewn-PoFp_NHuKwg1hih8qcPN7Kktp3I4Pok86VNtOtrlxjlsg==
expires: Fri, 18 Sep 2020 02:00:21 GMT

GET
H2 200 / Show response
www.googleadservices.com/pagead/conversion/842772104/ 2 KB
1 KB 36ms
36ms Script
text/javascript 172.217.21.194
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googleadservices.com/pagead/conversion/842772104/?random=1571410995352&cv=9&fst=1571410995352&num=1&value=0&label=FIJpCP6O4XkQiN3ukQM&guid=ON&resp=GooglemKTybQhCsO&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=120&u_java=false&u_nplug=0&u_nmime=0&gtm=2wgaa0&sendb=1&ig=1&frm=0&url=https%3A%2F%2Fwww.onclive.com%2Fweb-exclusives%2Ffda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer&tiba=FDA%20Grants%20Trastuzumab%20Deruxtecan%20Priority%20Review%20for%20HER2%2B%20Breast%20Cancer&bttype=purchase&async=1&rfmt=3&fmt=4

Requested by

Host: www.googleadservices.com
URL: https://www.googleadservices.com/pagead/conversion_async.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

172.217.21.194 , United States, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

fra16s12-in-f2.1e100.net

Software

cafe /

Resource Hash

b7d091542c1de346ac487b95abd446c5375620b75c5551beca9c33d928b8d3e2

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Fri, 18 Oct 2019 15:03:15 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: cafe
timing-allow-origin: *
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status: 200
cache-control: no-cache, must-revalidate
content-disposition: attachment; filename="f.txt"
content-type: text/javascript; charset=UTF-8
alt-svc: quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 1154
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 / Show response
googleads.g.doubleclick.net/pagead/viewthroughconversion/820251190/ 2 KB
1 KB 18ms
18ms Script
text/javascript 2a00:1450:4001:815::2002
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://googleads.g.doubleclick.net/pagead/viewthroughconversion/820251190/?random=1571410995355&cv=9&fst=1571410995355&num=1&guid=ON&resp=GooglemKTybQhCsO&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=120&u_java=false&u_nplug=0&u_nmime=0&gtm=2wgaa0&sendb=1&ig=1&frm=0&url=https%3A%2F%2Fwww.onclive.com%2Fweb-exclusives%2Ffda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer&tiba=FDA%20Grants%20Trastuzumab%20Deruxtecan%20Priority%20Review%20for%20HER2%2B%20Breast%20Cancer&async=1&rfmt=3&fmt=4

Requested by

Host: www.googleadservices.com
URL: https://www.googleadservices.com/pagead/conversion_async.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:815::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

cafe /

Resource Hash

fd0dfde0f3f0c57a27a8e629620f00c1f1002e032683bcb045b986e20c806109

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Fri, 18 Oct 2019 15:03:15 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: cafe
timing-allow-origin: *
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status: 200
cache-control: no-cache, must-revalidate
content-disposition: attachment; filename="f.txt"
content-type: text/javascript; charset=UTF-8
alt-svc: quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 1013
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 www-widgetapi.js Show response
s.ytimg.com/yts/jsbin/www-widgetapi-vfloS5Wsk/ 23 KB
9 KB 6ms
6ms Script
text/javascript 2a00:1450:4001:809::200e
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://s.ytimg.com/yts/jsbin/www-widgetapi-vfloS5Wsk/www-widgetapi.js

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/iframe_api

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:809::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

sffe /

Resource Hash

b631fccbe48b26dccef2b6eedeed2d6fb9020daf34dbc8010e587e280b6f498e

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Thu, 17 Oct 2019 11:35:55 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 98840
status: 200
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 8680
x-xss-protection: 0
last-modified: Wed, 16 Oct 2019 09:47:41 GMT
server: sffe
vary: Accept-Encoding, Origin
content-type: text/javascript
cache-control: public, max-age=691200
accept-ranges: bytes
timing-allow-origin: https://www.youtube.com
expires: Fri, 25 Oct 2019 11:35:55 GMT

GET
H2 200 box-74dcf4e32eff343c96838bf3a780ac1d.html
vars.hotjar.com/ Frame D385 0
0 310ms
21ms Document
text/html 147.75.84.33
Packet Host

General

Check archive.org

Show headers Download Go to

Full URL: https://vars.hotjar.com/box-74dcf4e32eff343c96838bf3a780ac1d.html
Requested by: Host: static.hotjar.com
URL: https://static.hotjar.com/c/hotjar-722008.js?sv=5
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 147.75.84.33 Parsippany, United States, ASN54825 (PACKET - Packet Host, Inc., US),
Reverse DNS
Software: /
Resource Hash

Request headers

:method: GET
:authority: vars.hotjar.com
:scheme: https
:path: /box-74dcf4e32eff343c96838bf3a780ac1d.html
pragma: no-cache
cache-control: no-cache
upgrade-insecure-requests: 1
user-agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode: nested-navigate
accept: text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site: cross-site
referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
accept-encoding: gzip, deflate, br
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode: nested-navigate
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Response headers

status: 200
date: Fri, 18 Oct 2019 15:03:15 GMT
content-type: text/html
content-length: 808
cache-control: max-age=31536000
content-encoding: br
last-modified: Thu, 17 Oct 2019 10:26:51 GMT
etag: "e97b43816dfbff056689db51ae5cdfc7"
section-io-origin-status: 200
section-io-origin-time-seconds: 0.053
vary: Accept-Encoding
accept-ranges: bytes
section-io-id: c8464fad001ec7bc40bea0ce8b2a6fd4

GET
H/1.1

200
OK

sc Show response
l.sharethis.com/
Redirect Chain

https://l.sharethis.com/pview?event=pview&version=buttons.js&lang=en&fpc=3c9de77-16ddf64e858-7327ece0-1&sessionID=1571410995288.70122&hostname=www.onclive.com&location=%2Fweb-exclusives%2Ffda-grant...
https://l.sharethis.com/sc?cm=ZGYABF2p1DYAAAAULhlPAw%3D%3D&uid=true&url=https%3A%2F%2Fwww.onclive.com%2Fweb-exclusives%2Ffda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer&sop...

51 B
506 B

24ms
24ms

XHR
text/plain

3.123.152.53
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://l.sharethis.com/sc?cm=ZGYABF2p1DYAAAAULhlPAw%3D%3D&uid=true&url=https%3A%2F%2Fwww.onclive.com%2Fweb-exclusives%2Ffda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer&sop=false
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 3.123.152.53 Frankfurt am Main, Germany, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: ec2-3-123-152-53.eu-central-1.compute.amazonaws.com
Software: /
Resource Hash: 6d2f20cb45eb935e987146fe8ce940469445db095825d928a8251674713ff697

Request headers

Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:18 GMT
Access-Control-Max-Age: 1728000
Content-Type: text/plain; charset=utf-8
Access-Control-Allow-Origin: https://www.onclive.com
Access-Control-Expose-Headers: stid
Cache-Control: no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials: true
Connection: keep-alive
X-Robots-Tag: noindex, nofollow
Access-Control-Allow-Headers: *
Content-Length: 51
Stid: ZGYABF2p1DYAAAAULhlPAw==

Redirect headers

Date: Fri, 18 Oct 2019 15:03:18 GMT
Content-Type: text/html; charset=utf-8
Access-Control-Allow-Origin: https://www.onclive.com
Access-Control-Max-Age: 1728000
P3p: policyref="/w3c/p3p.xml", CP="ALL DSP COR CURa ADMa DEVa TAIa PSAa PSDa OUR IND UNI COM NAV INT DEM"
Location: /sc?cm=ZGYABF2p1DYAAAAULhlPAw%3D%3D&uid=true&url=https%3A%2F%2Fwww.onclive.com%2Fweb-exclusives%2Ffda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer&sop=false
Access-Control-Expose-Headers: stid
Cache-Control: no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials: true
Connection: keep-alive
X-Robots-Tag: noindex, nofollow
Access-Control-Allow-Headers: *
Content-Length: 227
Stid: ZGYABF2p1DYAAAAULhlPAw==

GET
H2 200 ads Show response
securepubads.g.doubleclick.net/gampad/ 1 KB
877 B 83ms
82ms XHR
text/plain 172.217.23.98
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=519846286587573&correlator=1184346680028317&output=ldjh&impl=fifs&adsid=NT&eid=21063636%2C21064687&vrg=2019101401&guci=1.2.0.0.2.2.0.0&plat=1%3A536903688%2C2%3A536903688%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20191018&iu_parts=20642765%2Conclive%2Cspecialty%2Cbreast%2Cher2&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4%2C%2F0%2F1%2F2%2F3%2F4%2C%2F0%2F1%2F2%2F3%2F4%2C%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=728x90%2C300x250%2C300x250%7C300x600%2C728x90&prev_scp=pos%3DtopL%7Cpos%3DtopB%7Cpos%3DbottomB%7Cpos%3DbottomL&cookie_enabled=1&bc=31&abxe=1&lmt=1571410995&dt=1571410995444&dlt=1571410994932&idt=496&frm=20&biw=1585&bih=1200&oid=3&adxs=429%2C973%2C973%2C429&adys=-11%2C246%2C605%2C1850&adks=3495670744%2C2883668997%2C490120272%2C3495670771&ucis=1%7C2%7C3%7C4&ifi=1&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.onclive.com%2Fweb-exclusives%2Ffda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer&dssz=64&icsg=277798493093903&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=728x90%7C300x250%7C300x250%7C728x90&msz=728x90%7C300x250%7C300x250%7C728x90&ga_vid=588703558.1571410995&ga_sid=1571410995&ga_hid=1327822741&fws=0%2C0%2C0%2C0&ohw=0%2C0%2C0%2C0

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

172.217.23.98 , United States, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

fra16s45-in-f2.1e100.net

Software

cafe /

Resource Hash

903884661d9f707e8562369bb6847150a257665ee41fbed80a205f80ecadb609

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:15 GMT
content-encoding: br
x-content-type-options: nosniff
google-mediationgroup-id: -2,-2,-2,-2
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status: 200
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 248
x-xss-protection: 0
google-lineitem-id: -2,-2,-2,-2
pragma: no-cache
server: cafe
google-mediationtag-id: -2
google-creative-id: -2,-2,-2,-2
content-type: text/plain; charset=UTF-8
access-control-allow-origin: https://www.onclive.com
cache-control: no-cache, must-revalidate
access-control-allow-credentials: true
timing-allow-origin: *
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 pubads_impl_rendering_2019101401.js Show response
securepubads.g.doubleclick.net/gpt/ 64 KB
24 KB 60ms
60ms Script
text/javascript 172.217.23.98
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

172.217.23.98 , United States, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

fra16s45-in-f2.1e100.net

Software

sffe /

Resource Hash

f123fae1ceff20dea7ee2ff8895276a22cddecc8e0ef503b5e95419e76909a54

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:15 GMT
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Mon, 14 Oct 2019 13:08:16 GMT
server: sffe
vary: Accept-Encoding
content-type: text/javascript
status: 200
cache-control: private, immutable, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 24836
x-xss-protection: 0
expires: Fri, 18 Oct 2019 15:03:15 GMT

GET
H2 200 container.html
tpc.googlesyndication.com/safeframe/1-0-35/html/ 0
0 16ms
5ms Other
text/html 2a00:1450:4001:809::2001
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL: https://tpc.googlesyndication.com/safeframe/1-0-35/html/container.html
Requested by: Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2a00:1450:4001:809::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software: /
Resource Hash

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

GET
H/1.1 200
OK controltag.js.05f9d0dad02f8a1b0b028b868bc3a3e2 Show response
cdn.krxd.net/ctjs/ 248 KB
80 KB 30ms
30ms Script
application/javascript 151.101.12.175
Fastly

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.krxd.net/ctjs/controltag.js.05f9d0dad02f8a1b0b028b868bc3a3e2
Requested by: Host: cdn.krxd.net
URL: https://cdn.krxd.net/controltag/to98r5blo.js
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 151.101.12.175 Frankfurt am Main, Germany, ASN54113 (FASTLY - Fastly, US),
Reverse DNS
Software: /
Resource Hash: 7daa8dfc1349542ca90836b9becde99fa9bdf0b0599db5513c55ecbe556009a4

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

X-CDN-Backend: 4FrRTvEr9h480D4BywjehZ--F_Controltag_S3
Date: Fri, 18 Oct 2019 15:03:15 GMT
Content-Encoding: gzip
Age: 8041087
X-Cache: HIT
X-Cache-Hits: 3904365
Connection: keep-alive
Content-Length: 81058
X-Served-By: cache-fra19139-FRA
Last-Modified: Tue, 16 Jul 2019 17:45:11 GMT
X-Timer: S1571410995.484566,VS0,VE0
ETag: "05f9d0dad02f8a1b0b028b868bc3a3e2"
Content-Type: application/javascript
Via: 1.1 varnish
Cache-Control: public, max-age=315360000
Accept-Ranges: bytes
Expires: Fri, 13 Jul 2029 17:45:10 GMT

GET
H2 200 /
www.google.com/pagead/1p-user-list/820251190/ 42 B
110 B 21ms
20ms Image
image/gif 2a00:1450:4001:81d::2004
Google LLC

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.google.com/pagead/1p-user-list/820251190/?random=1571410995355&cv=9&fst=1571410800000&num=1&guid=ON&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=120&u_java=false&u_nplug=0&u_nmime=0&gtm=2wgaa0&sendb=1&frm=0&url=https%3A%2F%2Fwww.onclive.com%2Fweb-exclusives%2Ffda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer&tiba=FDA%20Grants%20Trastuzumab%20Deruxtecan%20Priority%20Review%20for%20HER2%2B%20Breast%20Cancer&async=1&fmt=3&is_vtc=1&random=3154044829&resp=GooglemKTybQhCsO&rmt_tld=0&ipr=y

Requested by

Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:81d::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

cafe /

Resource Hash

ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Security Headers

Name	Value
Content-Security-Policy	script-src 'none'; object-src 'none'
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Fri, 18 Oct 2019 15:03:15 GMT
x-content-type-options: nosniff
server: cafe
timing-allow-origin: *
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status: 200
cache-control: no-cache, no-store, must-revalidate
content-security-policy: script-src 'none'; object-src 'none'
content-type: image/gif
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 42
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 /
www.google.de/pagead/1p-user-list/820251190/ 42 B
110 B 23ms
22ms Image
image/gif 2a00:1450:4001:819::2003
Google LLC

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.google.de/pagead/1p-user-list/820251190/?random=1571410995355&cv=9&fst=1571410800000&num=1&guid=ON&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=120&u_java=false&u_nplug=0&u_nmime=0&gtm=2wgaa0&sendb=1&frm=0&url=https%3A%2F%2Fwww.onclive.com%2Fweb-exclusives%2Ffda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer&tiba=FDA%20Grants%20Trastuzumab%20Deruxtecan%20Priority%20Review%20for%20HER2%2B%20Breast%20Cancer&async=1&fmt=3&is_vtc=1&random=3154044829&resp=GooglemKTybQhCsO&rmt_tld=1&ipr=y

Requested by

Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:819::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

cafe /

Resource Hash

ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Security Headers

Name	Value
Content-Security-Policy	script-src 'none'; object-src 'none'
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Fri, 18 Oct 2019 15:03:15 GMT
x-content-type-options: nosniff
server: cafe
timing-allow-origin: *
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status: 200
cache-control: no-cache, no-store, must-revalidate
content-security-policy: script-src 'none'; object-src 'none'
content-type: image/gif
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 42
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2

200

/
www.google.de/pagead/1p-conversion/842772104/
Redirect Chain

https://googleads.g.doubleclick.net/pagead/viewthroughconversion/842772104/?random=436361640&cv=9&fst=*&num=1&value=0&label=FIJpCP6O4XkQiN3ukQM&guid=ON&resp=GooglemKTybQhCsO&u_h=1200&u_w=1600&u_ah=...
https://www.google.com/pagead/1p-conversion/842772104/?random=436361640&cv=9&fst=*&num=1&value=0&label=FIJpCP6O4XkQiN3ukQM&guid=ON&resp=GooglemKTybQhCsO&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=2...
https://www.google.de/pagead/1p-conversion/842772104/?random=436361640&cv=9&fst=*&num=1&value=0&label=FIJpCP6O4XkQiN3ukQM&guid=ON&resp=GooglemKTybQhCsO&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24...

42 B
110 B

20ms
20ms

Image
image/gif

2a00:1450:4001:819::2003
Google LLC

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.google.de/pagead/1p-conversion/842772104/?random=436361640&cv=9&fst=*&num=1&value=0&label=FIJpCP6O4XkQiN3ukQM&guid=ON&resp=GooglemKTybQhCsO&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=120&u_java=false&u_nplug=0&u_nmime=0&gtm=2wgaa0&sendb=1&ig=1&frm=0&url=https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer&tiba=FDA%20Grants%20Trastuzumab%20Deruxtecan%20Priority%20Review%20for%20HER2%2B%20Breast%20Cancer&async=1&fmt=3&ctc_id=CAIVAgAAAB0CAAAA&ct_cookie_present=false&sscte=1&crd=&gtd=&is_vtc=1&ocp_id=M9SpXaa0Govt3wPd2bDACg&eitems=ChAI8MWl7QUQuZXrzsqV56I0Eh0Anuk_jsaNbsrqbbL6hhsOd9FN0rXBHHkUX2z65g&random=3291780953&resp=GooglemKTybQhCsO&ipr=y

Requested by

Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:819::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

cafe /

Resource Hash

ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Security Headers

Name	Value
Content-Security-Policy	script-src 'none'; object-src 'none'
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Fri, 18 Oct 2019 15:03:15 GMT
x-content-type-options: nosniff
server: cafe
timing-allow-origin: *
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status: 200
cache-control: no-cache, no-store, must-revalidate
content-security-policy: script-src 'none'; object-src 'none'
content-type: image/gif
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 42
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma: no-cache
date: Fri, 18 Oct 2019 15:03:15 GMT
x-content-type-options: nosniff
server: cafe
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status: 302
content-type: image/gif
location: https://www.google.de/pagead/1p-conversion/842772104/?random=436361640&cv=9&fst=*&num=1&value=0&label=FIJpCP6O4XkQiN3ukQM&guid=ON&resp=GooglemKTybQhCsO&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=120&u_java=false&u_nplug=0&u_nmime=0&gtm=2wgaa0&sendb=1&ig=1&frm=0&url=https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer&tiba=FDA%20Grants%20Trastuzumab%20Deruxtecan%20Priority%20Review%20for%20HER2%2B%20Breast%20Cancer&async=1&fmt=3&ctc_id=CAIVAgAAAB0CAAAA&ct_cookie_present=false&sscte=1&crd=&gtd=&is_vtc=1&ocp_id=M9SpXaa0Govt3wPd2bDACg&eitems=ChAI8MWl7QUQuZXrzsqV56I0Eh0Anuk_jsaNbsrqbbL6hhsOd9FN0rXBHHkUX2z65g&random=3291780953&resp=GooglemKTybQhCsO&ipr=y
cache-control: no-cache, no-store, must-revalidate
content-security-policy: script-src 'none'; object-src 'none'
timing-allow-origin: *
alt-svc: quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length: 42
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 bundle.js Show response
assets.ubembed.com/universalscript/releases/v0.177.0/ 162 KB
46 KB 333ms
35ms Script
application/javascript 54.230.95.226
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://assets.ubembed.com/universalscript/releases/v0.177.0/bundle.js
Requested by: Host: 2bc72976f5be45bfaa237bd9b8fd5ddb.js.ubembed.com
URL: https://2bc72976f5be45bfaa237bd9b8fd5ddb.js.ubembed.com/
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 54.230.95.226 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: server-54-230-95-226.fra2.r.cloudfront.net
Software: AmazonS3 /
Resource Hash: de502b0503ebafcb2e8a7a7eea68518767d9044d13d7e4459727198b475bd04f

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Sun, 05 May 2019 00:52:14 GMT
content-encoding: gzip
last-modified: Tue, 02 Apr 2019 00:00:46 GMT
server: AmazonS3
age: 14393462
vary: Accept-Encoding
x-cache: Hit from cloudfront
content-type: application/javascript
status: 200
cache-control: max-age=31536000
x-amz-cf-pop: FRA2
x-amz-cf-id: 6C28AZc183bJF06adv4XSEQJqc8hBLBzv-cfuwZmD-EVCEmmCPMGdg==
via: 1.1 7a5407bd3564d5f8494603c5f2d0661f.cloudfront.net (CloudFront)

GET
H/1.1 200
OK e5cd00e5-5325-44ad-a52f-55ba78d3b281 Show response
consumer.krxd.net/consent/get/ 258 B
636 B 119ms
54ms Script
text/javascript 151.101.12.175
Fastly

General

Check archive.org

Show headers Download Go to

Full URL: https://consumer.krxd.net/consent/get/e5cd00e5-5325-44ad-a52f-55ba78d3b281?idt=device&dt=kxcookie&callback=Krux.ns.michaeljhennesyassociatesinc.kxjsonp_consent_get_0
Requested by: Host: cdn.krxd.net
URL: https://cdn.krxd.net/ctjs/controltag.js.05f9d0dad02f8a1b0b028b868bc3a3e2
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 151.101.12.175 Frankfurt am Main, Germany, ASN54113 (FASTLY - Fastly, US),
Reverse DNS
Software: /
Resource Hash: d5c95ae7e13f83632c9f698ab98a723237c9681595e359c20fb1b09d0356f7c5

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:15 GMT
Via: 1.1 varnish
Age: 0
Accept-Ranges: bytes
X-Served-By: consumer-a009-dub-prod.krxd.net, cache-fra19120-FRA
Vary: Accept-Encoding
X-Cache: MISS, MISS
Content-Type: text/javascript; charset=UTF-8
Content-Encoding: gzip
Cache-Control: max-age=1800
Connection: keep-alive
X-Age: 0
X-Timer: S1571410996.739992,VS0,VE25
Content-Length: 210
X-Cache-Hits: 0, 0

GET
H/1.1 200
OK e5cd00e5-5325-44ad-a52f-55ba78d3b281 Show response
consumer.krxd.net/consent/set/ 323 B
748 B 168ms
54ms Script
text/javascript 151.101.12.175
Fastly

General

Check archive.org

Show headers Download Go to

Full URL: https://consumer.krxd.net/consent/set/e5cd00e5-5325-44ad-a52f-55ba78d3b281?idt=device&dt=kxcookie&dc=1&al=1&tg=1&cd=1&sh=1&re=1&callback=Krux.ns.michaeljhennesyassociatesinc.kxjsonp_consent_set_1
Requested by: Host: cdn.krxd.net
URL: https://cdn.krxd.net/ctjs/controltag.js.05f9d0dad02f8a1b0b028b868bc3a3e2
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 151.101.12.175 Frankfurt am Main, Germany, ASN54113 (FASTLY - Fastly, US),
Reverse DNS
Software: /
Resource Hash: 4ab53b64edb4ecb2beb4e652109d627e6b534ae351777e677f45946e45c15161

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:15 GMT
Content-Encoding: gzip
Age: 0, 0
Accept-Ranges: bytes, bytes, bytes
X-Served-By: consumer-a010-dub-prod.krxd.net, cache-fra19120-FRA
Vary: Accept-Encoding
X-Cache: MISS, MISS
Content-Type: text/javascript; charset=UTF-8
Via: 1.1 varnish
Cache-Control: private, max-age=10
Connection: keep-alive
X-Age: 0
X-Timer: S1571410996.795955,VS0,VE24
Content-Length: 263
X-Cache-Hits: 0, 0

GET
H/1.1 200
OK e5cd00e5-5325-44ad-a52f-55ba78d3b281 Show response
consumer.krxd.net/consent/set/ 314 B
740 B 224ms
55ms Script
text/javascript 151.101.12.175
Fastly

General

Check archive.org

Show headers Download Go to

Full URL: https://consumer.krxd.net/consent/set/e5cd00e5-5325-44ad-a52f-55ba78d3b281?dc=1&al=1&tg=1&cd=1&sh=1&re=1&idt=bk&bk=did&callback=Krux.ns.michaeljhennesyassociatesinc.kxjsonp_consent_set_2
Requested by: Host: cdn.krxd.net
URL: https://cdn.krxd.net/ctjs/controltag.js.05f9d0dad02f8a1b0b028b868bc3a3e2
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 151.101.12.175 Frankfurt am Main, Germany, ASN54113 (FASTLY - Fastly, US),
Reverse DNS
Software: /
Resource Hash: 74d57ff5a89cb28fe021fc0adc2bbb6aa6b128a728b241aa3061b67fbb044738

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:15 GMT
Content-Encoding: gzip
Age: 0, 0
Accept-Ranges: bytes, bytes, bytes
X-Served-By: consumer-a008-dub-prod.krxd.net, cache-fra19120-FRA
Vary: Accept-Encoding
X-Cache: MISS, MISS
Content-Type: text/javascript; charset=UTF-8
Via: 1.1 varnish
Cache-Control: private, max-age=10
Connection: keep-alive
X-Age: 0
X-Timer: S1571410996.851280,VS0,VE25
Content-Length: 255
X-Cache-Hits: 0, 0

GET
H2 200 cookie2json Show response
beacon.krxd.net/ 79 B
242 B 117ms
38ms Script
text/javascript 54.171.133.34
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://beacon.krxd.net/cookie2json?callback=Krux.ns.michaeljhennesyassociatesinc.kxjsonp_3pevents
Requested by: Host: cdn.krxd.net
URL: https://cdn.krxd.net/ctjs/controltag.js.05f9d0dad02f8a1b0b028b868bc3a3e2
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 54.171.133.34 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: ec2-54-171-133-34.eu-west-1.compute.amazonaws.com
Software: /
Resource Hash: 1c2cf6ebae6d77ae5492af6d923b05998bd72e8bc7c5dc163c53d1bea615862b

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status: 200
date: Fri, 18 Oct 2019 15:03:15 GMT
cache-control: private, max-age=1800, s-max-age=1800
x-request-time: D=28 t=1571410995
content-type: text/javascript
x-served-by: beacon-n008-dub-prod.krxd.net

GET
H2 200 adsct
t.co/i/ 43 B
449 B 196ms
143ms Image
image/gif 104.244.42.5
Twitter Inc.

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://t.co/i/adsct?p_id=Twitter&p_user_id=0&txn_id=ny5qb&events=%5B%5B%22pageview%22%2Cnull%5D%5D&tw_sale_amount=0&tw_order_quantity=0&tw_iframe_status=0

Requested by

Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

104.244.42.5 , United States, ASN13414 (TWITTER - Twitter Inc., US),

Reverse DNS

Software

tsa_o /

Resource Hash

ac8778041fdb7f2e08ceb574c9a766247ea26f1a7d90fa854c4efcf4b361a957

Security Headers

Name	Value
Strict-Transport-Security	max-age=0
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:16 GMT
content-encoding: gzip
x-content-type-options: nosniff
status: 200, 200 OK
x-twitter-response-tags: BouncerCompliant
content-length: 65
x-xss-protection: 0
x-response-time: 115
pragma: no-cache
last-modified: Fri, 18 Oct 2019 15:03:16 GMT
server: tsa_o
x-frame-options: SAMEORIGIN
strict-transport-security: max-age=0
content-type: image/gif;charset=utf-8
cache-control: no-cache, no-store, must-revalidate, pre-check=0, post-check=0
x-connection-hash: af4ffee63ed3c80aab687196effaf68d
x-transaction: 00fa8e4900d7da9d
expires: Tue, 31 Mar 1981 05:00:00 GMT

GET
H/1.1 200
OK t.dhj Show response
t.sharethis.com/1/d/ 2 KB
1 KB 89ms
31ms Script
application/javascript 104.109.80.105
AKAMAI-ASN1

General

Check archive.org

Show headers Download Go to

Full URL

https://t.sharethis.com/1/d/t.dhj?rnd=1571410998510&cid=c010&dmn=www.onclive.com

Requested by

Host: ws.sharethis.com
URL: https://ws.sharethis.com/button/buttons.js

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

104.109.80.105 , Netherlands, ASN20940 (AKAMAI-ASN1, US),

Reverse DNS

a104-109-80-105.deploy.static.akamaitechnologies.com

Software

Resource Hash

489ab270ec4adf944f48c760125e133641bdc57c55d7433b8fbc9b2fb2958119

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Fri, 18 Oct 2019 15:03:18 GMT
Content-Encoding: gzip
X-Content-Type-Options: nosniff
P3P: policyref="/w3c/p3p.xml", CP="DSP LAW NID OUR DEL SAM BUS UNI PUR COM NAV INT STA PRE LOC OTC"
Vary: Accept-Encoding
Content-Type: application/javascript
Cache-Control: private, max-age=3600
Connection: keep-alive
X-Robots-Tag: noindex, nofollow, noindex, nofollow
Content-Length: 958
Expires: Fri, 18 Oct 2019 16:03:18 GMT

GET
H/1.1 200
OK t_.htm
t.sharethis.com/a/ Frame F511 0
0 45ms
44ms Document
text/html 104.109.80.105
AKAMAI-ASN1

General

Check archive.org

Show headers Download Go to

Full URL: https://t.sharethis.com/a/t_.htm?ver=0.312.14687&cid=c010
Requested by: Host: t.sharethis.com
URL: https://t.sharethis.com/1/d/t.dhj?rnd=1571410998510&cid=c010&dmn=www.onclive.com
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 104.109.80.105 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS: a104-109-80-105.deploy.static.akamaitechnologies.com
Software: /
Resource Hash

Request headers

Host: t.sharethis.com
Connection: keep-alive
Pragma: no-cache
Cache-Control: no-cache
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode: nested-navigate
Accept: text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
Sec-Fetch-Site: cross-site
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Accept-Encoding: gzip, deflate, br
Cookie: __stid=ZGYABF2p1DYAAAAULhlPAw==
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode: nested-navigate
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Response headers

Vary: Accept-Encoding
Content-Encoding: gzip
Content-Length: 1084
X-Robots-Tag: noindex, nofollow noindex, nofollow
Cache-Control: max-age=604800
Expires: Fri, 25 Oct 2019 15:03:18 GMT
Date: Fri, 18 Oct 2019 15:03:18 GMT
Connection: keep-alive
P3P: policyref="/w3c/p3p.xml", CP="DSP LAW NID OUR DEL SAM BUS UNI PUR COM NAV INT STA PRE LOC OTC"
Content-Type: text/html

GET
H2 200 optout_check Show response
beacon.krxd.net/ 82 B
240 B 38ms
38ms Script
text/javascript 54.171.133.34
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://beacon.krxd.net/optout_check?callback=Krux.ns.michaeljhennesyassociatesinc.kxjsonp_optOutCheck
Requested by: Host: cdn.krxd.net
URL: https://cdn.krxd.net/ctjs/controltag.js.05f9d0dad02f8a1b0b028b868bc3a3e2
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 54.171.133.34 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: ec2-54-171-133-34.eu-west-1.compute.amazonaws.com
Software: /
Resource Hash: 52f11a8e2eee4def47e5abaf34db7a53606fad8a84917685d325442e0c23a62e

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status: 200
date: Fri, 18 Oct 2019 15:03:21 GMT
cache-control: private, max-age=0, s-max-age=0
x-request-time: D=37 t=1571411001
content-type: text/javascript
x-served-by: beacon-n021-dub-prod.krxd.net

GET
H/1.1 200
OK get Show response
cdn.krxd.net/userdata/ 320 B
763 B 123ms
123ms Script
text/javascript 151.101.12.175
Fastly

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.krxd.net/userdata/get?pub=e5cd00e5-5325-44ad-a52f-55ba78d3b281&technographics=1&callback=Krux.ns.michaeljhennesyassociatesinc.kxjsonp_userdata
Requested by: Host: cdn.krxd.net
URL: https://cdn.krxd.net/ctjs/controltag.js.05f9d0dad02f8a1b0b028b868bc3a3e2
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 151.101.12.175 Frankfurt am Main, Germany, ASN54113 (FASTLY - Fastly, US),
Reverse DNS
Software: /
Resource Hash: 6c48d601b4be322c58f4260ea889eabd469f29de9535cc244f582fd6ee075a4c

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

X-CDN-Backend: 4FrRTvEr9h480D4BywjehZ--F_userdata_ash_prod_krxd_net___UserData_Service_V2
Date: Fri, 18 Oct 2019 15:03:21 GMT
Content-Encoding: gzip
Age: 0
X-Cache: MISS, MISS
Connection: keep-alive
X-Age: 0
Content-Length: 252
X-Served-By: userdata-a010-ash-prod.krxd.net, cache-fra19139-FRA
X-Timer: S1571411002.583942,VS0,VE94
Vary: Accept-Encoding
Content-Type: text/javascript
Via: 1.1 varnish
Cache-Control: private, max-age=3600
Accept-Ranges: bytes
X-Cache-Hits: 0, 0

GET
H2 200 fbevents.js Show response
connect.facebook.net/en_US/ 103 KB
23 KB 37ms
12ms Script
application/x-javascript 2a03:2880:f007:8:face:b00c:0:1
Facebook

General

Check archive.org

Show headers Download Go to

Full URL

https://connect.facebook.net/en_US/fbevents.js

Requested by

Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a03:2880:f007:8:face:b00c:0:1 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),

Reverse DNS

Software

Resource Hash

9404cee30e4489a7ed4d6de2dd92aa8e4386fd5ff1c81ebcea77f581952eac31

Security Headers

Name	Value
Content-Security-Policy	default-src * data: blob:;script-src .facebook.com .fbcdn.net .facebook.net .google-analytics.com .virtualearth.net .google.com 127.0.0.1:* .spotilocal.com: 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' ;connect-src .facebook.com facebook.com .fbcdn.net .facebook.net .spotilocal.com: wss://.facebook.com: https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';
Strict-Transport-Security	max-age=31536000; preload; includeSubDomains
X-Content-Type-Options	nosniff
X-Frame-Options	DENY
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security: max-age=31536000; preload; includeSubDomains
content-encoding: gzip
x-content-type-options: nosniff
status: 200
alt-svc: h3-23=":443"; ma=3600
content-length: 22458
x-xss-protection: 0
pragma: public
x-fb-debug: 6X0AB78lrHtzXLbr3Nz2RLJNksJq+p1kdp6c4fIiAk4QxpRi49od1J3RyBR1ebg81XQB98/ubjnbkdIz17Qw2g==
x-fb-trip-id: 1970646000
x-frame-options: DENY
date: Fri, 18 Oct 2019 15:03:21 GMT
vary: Accept-Encoding
content-type: application/x-javascript; charset=utf-8
cache-control: public, max-age=1200
content-security-policy: default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';
expires: Sat, 01 Jan 2000 00:00:00 GMT

GET
H2 200 1189447974533468 Show response
connect.facebook.net/signals/config/ 280 KB
66 KB 65ms
65ms Script
application/x-javascript 2a03:2880:f007:8:face:b00c:0:1
Facebook

General

Check archive.org

Show headers Download Go to

Full URL

https://connect.facebook.net/signals/config/1189447974533468?v=2.9.5&r=stable

Requested by

Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a03:2880:f007:8:face:b00c:0:1 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),

Reverse DNS

Software

Resource Hash

41b57d59692297b4ad54fd44fc05500f9486f2caa9d8ba4b2885000098797dfe

Security Headers

Name	Value
Content-Security-Policy	default-src * data: blob:;script-src .facebook.com .fbcdn.net .facebook.net .google-analytics.com .virtualearth.net .google.com 127.0.0.1:* .spotilocal.com: 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' ;connect-src .facebook.com facebook.com .fbcdn.net .facebook.net .spotilocal.com: wss://.facebook.com: https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
Strict-Transport-Security	max-age=31536000; preload; includeSubDomains
X-Content-Type-Options	nosniff
X-Frame-Options	DENY
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security: max-age=31536000; preload; includeSubDomains
content-encoding: gzip
x-content-type-options: nosniff
status: 200
alt-svc: h3-23=":443"; ma=3600
x-xss-protection: 0
pragma: public
x-fb-debug: YqY5bYztbo+Ln3HSG3nzMS94B/IYRg/ihUEbwpR3zMBte2a9zLzghOghK/9bviY/s29G6m2Vz86lLX52I/riVw==
x-fb-trip-id: 1970646000
x-frame-options: DENY
date: Fri, 18 Oct 2019 15:03:21 GMT
vary: Accept-Encoding
content-type: application/x-javascript; charset=utf-8
cache-control: public, max-age=1200
content-security-policy: default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
expires: Sat, 01 Jan 2000 00:00:00 GMT

GET
H2 200 /
www.facebook.com/tr/ 44 B
349 B 37ms
12ms Image
image/gif 2a03:2880:f107:83:face:b00c:0:25de
Facebook

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.facebook.com/tr/?id=1189447974533468&ev=PageView&dl=https%3A%2F%2Fwww.onclive.com%2Fweb-exclusives%2Ffda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer&rl=&if=false&ts=1571411001710&sw=1600&sh=1200&v=2.9.5&r=stable&ec=0&o=30&fbp=fb.1.1571411001709.1278171510&it=1571411001622&coo=false&rqm=GET

Requested by

Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a03:2880:f107:83:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),

Reverse DNS

Software

proxygen-bolt /

Resource Hash

10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:21 GMT
last-modified: Fri, 21 Dec 2012 00:00:01 GMT
server: proxygen-bolt
strict-transport-security: max-age=31536000; includeSubDomains
content-type: image/gif
status: 200
cache-control: no-cache, must-revalidate, max-age=0
alt-svc: h3-23=":443"; ma=3600
content-length: 44
expires: Fri, 18 Oct 2019 15:03:21 GMT

GET
H2 204 pixel.gif
beacon.krxd.net/ 0
319 B 40ms
39ms Image
text/plain 54.171.133.34
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://beacon.krxd.net/pixel.gif?source=smarttag&fired=user_data_timeout&confid=to98r5blo&_kpid=e5cd00e5-5325-44ad-a52f-55ba78d3b281&_kcp_s=onclive&_kcp_d=www.onclive.com&_knifr=3&_kua_kx_tz=-120&rtsegs=t93v5a8pc&_kua_kx_lang=en-us&_kua_kx_tech_browser_language=en-us&_kpa_url_path_1=web-exclusives&_kpa_url_path_2=fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer&_kpa_meta_keywords=her2&_kpa_domain=onclive.com&_kpa_page_title=FDA%20Grants%20Trastuzumab%20Deruxtecan%20Priority%20Review%20for%20HER2%2B%20Breast%20Cancer&_kpa_page_keywords=her2&_kpa_page_description=The%20FDA%20has%20granted%20a%20priority%20review%20designation%20to%20a%20biologics%20license%20application%20for%20%5Bfam-%5D%20trastuzumab%20deruxtecan%20(DS-8201)%20for%20the%20treatment%20of%20patients%20with%20HER2-positive%20metastatic%20breast%20cancer.&t_navigation_type=0&t_dns=11&t_tcp=3219&t_http_request=-1&t_http_response=84&t_content_ready=4335&t_window_load=0&t_redirect=0&interchange_ran=false&userdata_was_requested=true&userdata_did_respond=false&store_segs_after=t93v5a8pc&sview=1&kplt0=41165&kplt1=39220&kplt2=39580&kplt3=41214&jsonp_requests=https%3A%2F%2Fconsumer.krxd.net%2Fconsent%2Fget%2Fe5cd00e5-5325-44ad-a52f-55ba78d3b281%2C121%2Chttps%3A%2F%2Fconsumer.krxd.net%2Fconsent%2Fset%2Fe5cd00e5-5325-44ad-a52f-55ba78d3b281%2C170%2Chttps%3A%2F%2Fconsumer.krxd.net%2Fconsent%2Fset%2Fe5cd00e5-5325-44ad-a52f-55ba78d3b281%2C226%2Chttps%3A%2F%2Fbeacon.krxd.net%2Fcookie2json%2C118%2Chttps%3A%2F%2Fbeacon.krxd.net%2Foptout_check%2C39%2Chttps%3A%2F%2Fcdn.krxd.net%2Fuserdata%2Fget%2C125
Requested by: Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 54.171.133.34 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: ec2-54-171-133-34.eu-west-1.compute.amazonaws.com
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status: 204
date: Fri, 18 Oct 2019 15:03:21 GMT
cache-control: private, no-cache, no-store
x-request-time: D=41 t=1571411001
p3p: policyref="https://cdn.krxd.net/kruxcontent/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"
x-served-by: beacon-n012-dub-prod.krxd.net

GET
H2 200 /
www.facebook.com/tr/ 44 B
146 B 13ms
12ms Image
image/gif 2a03:2880:f107:83:face:b00c:0:25de
Facebook

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.facebook.com/tr/?id=1189447974533468&ev=Microdata&dl=https%3A%2F%2Fwww.onclive.com%2Fweb-exclusives%2Ffda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer&rl=&if=false&ts=1571411002219&cd[DataLayer]=%5B%5D&cd[Meta]=%7B%22title%22%3A%22FDA%20Grants%20Trastuzumab%20Deruxtecan%20Priority%20Review%20for%20HER2%2B%20Breast%20Cancer%22%2C%22meta%3Akeywords%22%3A%22her2%22%2C%22meta%3Adescription%22%3A%22The%20FDA%20has%20granted%20a%20priority%20review%20designation%20to%20a%20biologics%20license%20application%20for%20%5Bfam-%5D%20trastuzumab%20deruxtecan%20(DS-8201)%20for%20the%20treatment%20of%20patients%20with%20HER2-positive%20metastatic%20breast%20cancer.%22%7D&cd[OpenGraph]=%7B%22og%3Atitle%22%3A%22FDA%20Grants%20Trastuzumab%20Deruxtecan%20Priority%20Review%20for%20HER2%2B%20Breast%20Cancer%22%2C%22og%3Aimage%22%3A%22https%3A%2F%2Fonclive.s3.amazonaws.com%2F_media%2F_upload_image%2FJose_Baselga_thumb.jpg%22%2C%22og%3Asite_name%22%3A%22OncLive%22%2C%22og%3Atype%22%3A%22article%22%2C%22og%3Aurl%22%3A%22https%3A%2F%2Fwww.onclive.com%2Fweb-exclusives%2Ffda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer%22%2C%22og%3Adescription%22%3A%22The%20FDA%20has%20granted%20a%20priority%20review%20designation%20to%20a%20biologics%20license%20application%20for%20%5Bfam-%5D%20trastuzumab%20deruxtecan%20(DS-8201)%20for%20the%20treatment%20of%20patients%20with%20HER2-positive%20metastatic%20breast%20cancer.%22%7D&cd[Schema.org]=%5B%5D&cd[JSON-LD]=%5B%5D&sw=1600&sh=1200&v=2.9.5&r=stable&ec=1&o=30&fbp=fb.1.1571411001709.1278171510&it=1571411001622&coo=false&es=automatic&rqm=GET

Requested by

Host: www.onclive.com
URL: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a03:2880:f107:83:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),

Reverse DNS

Software

proxygen-bolt /

Resource Hash

10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:22 GMT
last-modified: Fri, 21 Dec 2012 00:00:01 GMT
server: proxygen-bolt
strict-transport-security: max-age=31536000; includeSubDomains
content-type: image/gif
status: 200
cache-control: no-cache, must-revalidate, max-age=0
alt-svc: h3-23=":443"; ma=3600
content-length: 44
expires: Fri, 18 Oct 2019 15:03:22 GMT

POST
H2 200 beam.php Show response
lucid.mjhassoc.com/ 80 B
457 B 148ms
148ms XHR
text/html 52.20.98.150
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://lucid.mjhassoc.com/beam.php
Requested by: Host: ajax.googleapis.com
URL: https://ajax.googleapis.com/ajax/libs/jquery/2.1.4/jquery.min.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.20.98.150 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-52-20-98-150.compute-1.amazonaws.com
Software: Apache/2.4.7 (Ubuntu) / PHP/5.5.9-1ubuntu4.27
Resource Hash: 9f7ae2107494ca2ac95f71a67c90319dec03f1ac6d1e218565e148f65fea2ec6

Request headers

Accept: application/json, text/javascript, */*; q=0.01
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode: cors
Content-Type: application/x-www-form-urlencoded; charset=UTF-8

Response headers

date: Fri, 18 Oct 2019 15:03:25 GMT
content-encoding: gzip
server: Apache/2.4.7 (Ubuntu)
status: 200
x-powered-by: PHP/5.5.9-1ubuntu4.27
vary: Accept-Encoding
content-type: text/html
access-control-allow-origin: https://www.onclive.com
access-control-allow-credentials: true
content-length: 97

GET
H2 200 adsct Show response
analytics.twitter.com/i/ 31 B
634 B 195ms
143ms Script
application/javascript 104.244.42.67
Twitter Inc.

General

Check archive.org

Show headers Download Go to

Full URL

https://analytics.twitter.com/i/adsct?p_id=Twitter&p_user_id=0&txn_id=ny5qb&events=%5B%5B%22pageview%22%2Cnull%5D%5D&tw_sale_amount=0&tw_order_quantity=0&tw_iframe_status=0&tpx_cb=twttr.conversion.loadPixels&tw_document_href=https%3A%2F%2Fwww.onclive.com%2Fweb-exclusives%2Ffda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Requested by

Host: static.ads-twitter.com
URL: https://static.ads-twitter.com/uwt.js

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

104.244.42.67 , United States, ASN13414 (TWITTER - Twitter Inc., US),

Reverse DNS

Software

tsa_o /

Resource Hash

df3e003cc30e9bdd0313100e8ee5d468070b4b34d11ad355f276a356d4b9c7bf

Security Headers

Name	Value
Strict-Transport-Security	max-age=631138519
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 18 Oct 2019 15:03:25 GMT
content-encoding: gzip
x-content-type-options: nosniff
p3p: CP="CAO DSP LAW CURa ADMa DEVa TAIa PSAa PSDa IVAa IVDa OUR BUS IND UNI COM NAV INT"
status: 200, 200 OK
x-twitter-response-tags: BouncerCompliant
strict-transport-security: max-age=631138519
content-length: 57
x-xss-protection: 0
x-response-time: 118
pragma: no-cache
last-modified: Fri, 18 Oct 2019 15:03:25 GMT
server: tsa_o
x-frame-options: SAMEORIGIN
content-type: application/javascript;charset=utf-8
cache-control: no-cache, no-store, must-revalidate, pre-check=0, post-check=0
x-connection-hash: 2c2dda41117115ecbfd59a0ae5955993
x-transaction: 00fe3b9d00c30c04
expires: Tue, 31 Mar 1981 05:00:00 GMT

GET
H2 200 index.html
ws.sharethis.com/secure/ Frame C778 0
0 7ms
6ms Document
text/html 2600:9000:21f3:6200:3:c04e:c780:93a1
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://ws.sharethis.com/secure/index.html
Requested by: Host: ws.sharethis.com
URL: https://ws.sharethis.com/button/async-buttons.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 2600:9000:21f3:6200:3:c04e:c780:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software: nginx/1.12.2 /
Resource Hash

Request headers

:method: GET
:authority: ws.sharethis.com
:scheme: https
:path: /secure/index.html
pragma: no-cache
cache-control: no-cache
upgrade-insecure-requests: 1
user-agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode: nested-navigate
accept: text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site: cross-site
referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer
accept-encoding: gzip, deflate, br
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode: nested-navigate
Referer: https://www.onclive.com/web-exclusives/fda-grants-trastuzumab-deruxtecan-priority-review-for-her2-breast-cancer

Response headers

status: 200
content-type: text/html
content-length: 2090
content-encoding: gzip
date: Fri, 18 Oct 2019 01:19:58 GMT
etag: W/"5d9e5f51-1ade"
last-modified: Wed, 09 Oct 2019 22:29:37 GMT
server: nginx/1.12.2
x-robots-tag: noindex, nofollow
vary: Accept-Encoding
x-cache: Hit from cloudfront
via: 1.1 56fad5a50ef67bd961b9722ed0931839.cloudfront.net (CloudFront)
x-amz-cf-pop: FRA2-C2
x-amz-cf-id: vA97GyKmo_RLMHi4S5WDxOWZ5DjXOw73rMbpT3DzIhchMLOCMaHNpA==
age: 49407

Verdicts & Comments Add Verdict or Comment

139 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

0 Cookies

Cookies are little pieces of information stored in the browser of a user. Whenever a user visits the site again, he will also send his cookie values, thus allowing the website to re-identify him even if he changed locations. This is how permanent logins work.

6 Console Messages

A page may trigger messages to the console to be logged. These are often error messages about being unable to load a resource or execute a piece of JavaScript. Sometimes they also provide insight into the technology behind a website.

Source	Level	URL Text
console-api	error	URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js(Line 1) Message: TypeError: Cannot read property '0' of null
console-api	error	URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js(Line 1) Message: TypeError: Cannot read property '0' of null
console-api	error	URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js(Line 1) Message: TypeError: Cannot read property '0' of null
console-api	error	URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js(Line 1) Message: TypeError: Cannot read property '0' of null
console-api	error	(Line 1) Message: [object Object]
console-api	error	(Line 1) Message: [object Object]

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header	Value
Content-Security-Policy	upgrade-insecure-requests

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

2bc72976f5be45bfaa237bd9b8fd5ddb.js.ubembed.com
adservice.google.com
adservice.google.de
ajax.googleapis.com
analytics.twitter.com
assets.ubembed.com
beacon.krxd.net
c.sharethis.mgr.consensu.org
cdn.jsdelivr.net
cdn.krxd.net
connect.facebook.net
consumer.krxd.net
d14575uifa02kd.cloudfront.net
googleads.g.doubleclick.net
l.sharethis.com
lucid.mjhassoc.com
mailview.bulletinhealthcare.com
onclive.s3.amazonaws.com
s.ytimg.com
s3.amazonaws.com
script.hotjar.com
securepubads.g.doubleclick.net
static.ads-twitter.com
static.hotjar.com
stats.g.doubleclick.net
t.co
t.sharethis.com
tpc.googlesyndication.com
use.fontawesome.com
vars.hotjar.com
ws.sharethis.com
www.facebook.com
www.google-analytics.com
www.google.com
www.google.de
www.googleadservices.com
www.googletagmanager.com
www.googletagservices.com
www.onclive.com
www.youtube.com
104.109.80.105
104.244.42.5
104.244.42.67
143.204.98.216
147.75.33.59
147.75.84.33
151.101.112.157
151.101.12.175
151.101.13.131
172.217.21.194
172.217.23.98
23.111.9.35
2600:9000:2156:8600:c:a9b7:ddc0:93a1
2600:9000:21f3:6200:3:c04e:c780:93a1
2a00:1450:4001:800::200a
2a00:1450:4001:809::2001
2a00:1450:4001:809::200e
2a00:1450:4001:815::2002
2a00:1450:4001:815::200e
2a00:1450:4001:819::2003
2a00:1450:4001:81a::2008
2a00:1450:4001:81d::2004
2a00:1450:400c:c04::9a
2a03:2880:f007:8:face:b00c:0:1
2a03:2880:f107:83:face:b00c:0:25de
2a04:4e42:1b::621
3.123.152.53
52.20.98.150
52.206.141.94
52.216.164.101
52.216.184.59
54.171.133.34
54.230.95.226
69.174.55.131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www.onclive.com Open in urlscan Pro 52.206.141.94 Public Scan

Summary

urlscan.io Verdict: No classification

Domain & IP information

Screenshot Live screenshot Full Image

Page URL History Show full URLs

Detected technologies

Page Statistics

121 Requests

100 %HTTPS

41 %IPv6

28 Domains

40 Subdomains

32 IPs

6 Countries

9763 kBTransfer

11562 kBSize

0 Cookies

27 Outgoing links

Page URL History

Redirected requests

121 HTTP transactions Everything HTML Script AJAX CSS Image Expand all 0 data transactions

Request headers

Response headers

Redirect headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Redirect headers

Request headers

Response headers

Redirect headers

Request headers

Response headers

Redirect headers

Request headers

Response headers

Redirect headers

Request headers

Response headers

Redirect headers

www.onclive.com Open in urlscan Pro
52.206.141.94 Public Scan

Screenshot
Live screenshot

Full Image

121
Requests

100 %
HTTPS

41 %
IPv6

28
Domains

40
Subdomains

32
IPs

6
Countries

9763 kB
Transfer

11562 kB
Size

0
Cookies

121 HTTP transactions
0 data transactions